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ABSTRACT
Pevey, Ryan Shaun The Differential Expression of Gene Cohorts Over the Course of
Development in Type I and Type II Layer V Pyramidal Neurons of the Mouse
Medial Prefrontal and Primary Somatosensory Cortex. Unpublished Master of
Science thesis, University of Northern Colorado, 2017.
Two of the most challenging problems in neuroscience may be the characterization of
different neuron types and determining the various decision points over the course of
development that defines those different cell types. Part of the problem is that for the
clear majority of neuron types, no single gene so far has been shown to act as a type
marker. Instead it seems that signatures involving multiple genes are necessary to define
each type. The identity of the genes in these signatures remains an important gap in our
knowledge. However, recent developments in bioinformatics have produced population
level transcript sequencing of single cell types. These datasets provide a rich resource for
identifying marker genes for neuronal type and for decoding their developmental timeline
as well. Here I present a method for analyzing cortical neuron datasets and verifying the
expression profiles of the identified marker-gene protein products. Type I and Type II
pyramidal neurons within layer V of the neocortex are important output neurons of the
neocortical circuit and are associated with several brain disorders such as Schizophrenia,
Alzheimer’s and some types of Autism. They are found in all regions of the neocortex
and are defined by their axonal targets; Type I neurons project subcortically while Type
II neurons project contralaterally. In the mouse, the primary somatosensory cortex is
probably the most studied region. The less studied medial prefrontal cortex is associated
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with executive functions such as working memory and decision making processes.
Fourteen putative genetic type markers for layer V pyramidal neurons of the mouse
medial prefrontal and primary somatosensory cortices (seven Type I, seven Type II) were
identified and eight were assessed for protein expression via fluorescence
immunohistochemistry at ages P1 and P7. This is the first study assessing the protein
expression of PCP4 and TCERG1L in Layer V pyramidal neurons in comparison
between the two brain regions. This is also the first time that PCP4 has been shown to be
present in Type I neurons of the mouse medial prefrontal cortex or at postnatal ages.
Ultimately, PCP4 was determined to be a viable Type I marker at both ages and in both
cortical locations. Finding new marker genes for these neurons is important for
understanding not only their function and development but also for that of the whole
neocortex. Once identified, their role in function and development can be determined for
each neuron type which may help shed light on some of the disorders associated with
them.
Keywords: colocalization, contralateral, callosal, cufflinks, FIJI, Icy, Layer 5, Layer V,
mPFC, marker gene, medial prefrontal, neuronal subtype, P1, P7, PCP4, prefrontal,
primary somatosensory, pyramidal neuron, SSp, somatosensory, subcortical, TCERG1L,
tophat, Type I, Type II, Type 1, Type 2
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CHAPTER I
INTRODUCTION
Specific Aims
This project addresses the gap in our knowledge about the molecular identities of
two specific pyramidal neuron cell types that reside within layer V of the medial
prefrontal cortex (mPFC) and primary somatosensory cortex (SSp) of the mouse brain.
The characteristic difference between these two cell types, designated Type I and Type II,
is the target of their axonal projections[1]. Type I neurons project their axons
subcortically to different tissues below the cortex, such as the pons in the brainstem[2].
Type II neurons project their axons contralaterally to the same mirror image location in
the opposite hemisphere of the neocortex[2]. These neuron types are partially
characterized based on their cellular morphology, their electrical properties, and the
various contacts that they make with other cells. However, the molecular and
developmental pathway that determines these characters is still unknown. The goal of this
project was to identify novel marker signatures for these two cell types, but was also
importantly to identify functionally important gene clusters that provide insight into the
physiological differences between the two cell types.

H1

The differential gene expression between Type I and Type II neurons is
indicative of the physiological and morphological differences between the
two cell types, with expected gene clusters including genes involved with
neural development and differentiation.
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H2

Tissue sections double stained with markers established in the literature
and the proposed markers, will align with their predicted marker identities
from Hypothesis 1.
Neocortical Development

The mammalian neocortex is a very complex tissue with many different cell types
and connections between them[3]. The development of these cell types are determined by
a programmatic series of molecular determinants that carry them through to
maturity[2,3]. The various regions of the neocortex are established relatively early, at
embryonic day 9.5 (E9.5) in mice, by well-known diffusible morphogens such as Fgf8,
Wnt’s, Bmp’s, Couptf1 and Sp8[2]. This early regionalization provides a two-dimensional
coordinate to each cell population and initiates the area specific development associated
with that region. Each region then later specializes for a specific type of information
processing, for example audio or visual information.
At this point in development (E9.5), the mouse neocortical lamina is made up of
undifferentiated neuroepithelial cells which differentiate into radial glial cells
establishing a ventricular proliferation zone towards the core of the tissue[2]. The radial
glial cells have a bipolar morphology with processes that span the entire lamina of the
developing cortex and are progenitors that produce neurons via asymmetrical cellular
division[2]. The newly born neurons climb the radial glial processes from the ventricular
surface to the pial surface in an inside out fashion[2]. In this manner each successive
round of neurons pushes past the previous ones, creating the layered structure of the
neocortex[2,4]. There are up to six layers of neurons in the neocortex, with each layer
specializing for its own function within the neural circuit[5]. The outermost layer,
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furthest from the ventricle, is denoted layer I and the inner most layer, closest to the
ventricle, is layer VI.
Starting at E10.5 the radial glia begin producing the first excitatory neurons, the
subplate neurons[6]. Around E11.5 the corticothalamic projection neurons, which largely
constitute layer VI, are beginning to migrate out of the ventricular zone[2]. The birth of
Type I cells of layer V begins at E12.5 and peaks at E13.5[2]. Type II cells begin to be
born at E12.5 as well and continue to increase in number until E15.5 with later born
callosal projection neurons migrating to superficial layers II/III[2]. The birth of layer IV
neurons start on E14.5, the last layer to start, and they migrate past the layer II/III
neurons and retreat back to layer IV[2,7]. Not every brain region has a layer IV. For
example, the primary somatosensory cortex in the mouse does have a layer IV but the
medial prefrontal cortex does not.
The primary somatosensory and medial prefrontal cortex are the two brain regions
that are considered in this project. The primary somatosensory cortex processes
information from the sense of touch and is one of the most studied regions in the
neocortex. The less studied medial prefrontal cortex is a higher-order processing center
associated with executive functions such as decision-making and working memory tasks.
They are also in separate functional modules within the neocortical connectome[8] which
might lead to physiological or developmental differences between regions.
There are some differences in tissue properties between different brain regions[9].
For example, the thickness of the individual layers can vary between different regions.
The differential gene expression of analogous cell types between different regions of the
neocortex has not been vigorously studied, but there are some notable regionalizations.
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LIM domain only 4 (Lmo4), for example, is expressed in postmitotic neurons of higherorder sensory areas and motor cortex; but is absent in primary somatosensory, audio and
visual cortices[2].
We have known about some of these cytoarchitectural regionalizations for over a
century. Even though there are well known regional differences on the tissue level, it has
been hypothesized that these differences arise largely from differing quantities of specific
cell types in any given region, while the individual cells of each type remain analogous in
function regardless of regional affiliation[5]. Therefore, a layer V pyramidal neuron in
the sensorimotor cortex may hypothetically perform the same general functions as a layer
V pyramidal neuron of the medial prefrontal cortex.
The axons, the projections that send out information integrated by the neuron,
reach their respective targets around birth (postnatal day 0) and invade them in the days
immediately after (P0-P5 in the rat)[10]. Axon guidance is a complex process involving
ligands produced by the surrounding tissues and axonal targets, which bind to receptors
on axon growth cones and mediate restructuring of the actin cytoskeleton to promote
either attraction or repulsion[11]. Ephrins are a class of cell surface proteins that can act
as both attractant and repulsive signals which bind to EPH receptors on the axonal growth
cone[12]. Netrins are secreted repulsive proteins which bind to UNC receptors on the
growth cone[13]. Semaphorins can be either secreted or cell surface proteins acting as
repulsive signals that bind to Plexin receptors[12]. All of these classes of proteins are
highly conserved throughout the animal kingdom and have been observed in the guidance
of axons in C. elegans and D. melanogaster, as well as all mammals[11].
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The next major step in development for these neurons is synaptogenesis, where
the synapses that carry information from one neuron to the next are finally formed. This
stage of development begins at P7 and reaches its peak by P14[14]. This process occurs
concurrently with dendritogenesis, the process by which the projections form that receive
information from other cells (dendrites), also reaches peak activity at age P14[15].
Neuronal Gene Expression
It has been particularly difficult to identify the molecular underpinnings of the
various decision points for cell types in the neocortex[3]. Many labs have focused on
specific marker proteins for the cell types that they study. These markers are often used
by only one or a small group of labs, leading to potential confusion about the identities of
those cell types. To further complicate the issue, current studies have concluded that no
one marker can positively identify a single cell type, but that signatures of multiple genes
are needed to identify one cell population from another[16]. Therefore, the
documentation of new markers is essential to understand the identities and function of
individual cell types[10,16].
Thus, the identification of novel marker genes is currently a primary focus in the
field, with several groups doing similar work to try to better define the molecular
identities of each neuron type[17,18,19,20]. Most of these studies are considering many
different cell types (up to dozens) at once, or even looking at transcription of multiple cell
types together at the gross tissue level. This study focuses specifically on Type I and II
layer V pyramidal neurons, which might provide less noise and greater resolution of the
differences between just the two closely related neurons.
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Type I neurons are distinct from Type II neurons in their gene expression,
hodology (connections to other neurons), morphology and electrophysiological
behavior[1]. The aim of this project is to address the gap in our knowledge of their gene
expression. Their hodological differences have already been mentioned, Type I neurons
project their axons subcortically and Type II neurons project contralaterally. They are
morphologically distinct in that Type I neurons tend to be larger with more densely
branching apical dendrites that reach up into layer I of the neocortex, while Type II
neurons tend to be slightly smaller with more sparsely branched apical dendrites[21].
Electrophysiologically, Type I neurons display a prominent h-current and bursting
behavior[21]. That is, after the neurons fire an action potential the membrane voltage can
display a depolarization, bringing it to the threshold for another action potential, like
pace-maker cells in the heart (h-current). That causes the neuron to have the tendency to
rapidly fire another action potential even if the subsequent stimuli are less than the
previous ones, which can lead to several action potentials following each other in rapid
succession (bursting). Type II neurons lack the prominent h-current and do not show
bursting activity[21].
Classification of Layer V Neurons
There are two gold standard methods for positively identifying the two neuron
types. First, they can be determined electrophysiologically via patch clamp to look for the
electrical behaviors of each[22]. This is the most reliable method for determining the
identity of an individual neuron because the differences between the two (h-current and
bursting) are pronounced. However, the skillset for electrophysiology is difficult to
master, is relatively expensive and only allows determination of one neuron at a time.
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The other method involves retrograde labelling of neurons through latex
microbeads or similar technique[21]. This process involves making an injection of some
type of labelling compound, such as latex microbeads, into the regions that the axons
project to. The labelling compound is then picked up by the axons of the target neurons
and transported back to the soma of the cell. This approach has the advantage of being
able to label hundreds of cells at once and is less expensive than electrophysiology, but
still requires technical skills as well as several days of incubation before the cells are
fully labelled. This method requires very precise control over the location of the injection
sites to within a few tens of micrometers with the use of stereotaxic equipment to ensure
the correct brain regions are targeted. Both methods are also relatively uncommon
laboratory techniques and require expensive specialty equipment so their use is limited to
relatively few labs.
The use of immunohistochemistry to look for protein markers has advantages as
an alternative to these methods because it is less expensive and requires a simpler skill set
in one of the most common techniques in the modern molecular biology lab. It is a
shorter methodology than microbead retrograde labelling, and a large number of
commercial antibodies are available, making this a very flexible and customizable
technique for labelling cells. One of the biggest advantages, as with microbead labelling,
is the ability to probe entire tissues at once to find hundreds to thousands of the target
cells.
The difficulty comes from the need to use multiple antibodies on each tissue, as
well as all of the risks of multiple channel fluorescence immunohistochemistry[23]. The
antibodies used require careful coordination to ensure that the primary antibodies bind
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their targets without nonspecific labelling. Each primary antibody was raised in a specific
organism (e.g. Rat, Rabbit, Mouse) and the secondary antibodies are designed to bind
specifically to the antibodies of a particular species. Therefore, if multiple primary
antibodies are being used, only one of each species can be used in any one experiment.
The secondaries, if used in fluorescence microscopy, will bind to the primary antibody of
a specific species and will absorb a specific wavelength of light and emit light of a
different wavelength. The secondary antibodies must also be selected carefully to avoid
emission spectra that overlap.
CTIP2 is well established in the literature as a Type I marker protein, and SATB2
is a well-established Type II marker protein[3,9,16,17]. Both are transcription factors
associated with axon guidance, CTIP2 is crucial for Type I neurons finding their
subcortical targets, while SATB2 suppresses CTIP2 expression and guides the axons
contralaterally[24,25]. However, there is some overlap between the two, so neither can be
used alone to definitively identify either type. When used in conjunction, a neuron that
displays high expression of CTIP2 and low expression of SATB2 can be positively
identified as Type I and a neuron with high expression of SATB2 and no CTIP2
expression can be positively identified as Type II[17]. Finding new marker proteins
would add to our ability to identify large quantities of cell types in a given tissue sample.
As mice age, many of the markers identified in Hypothesis 1 were predicted to
decrease in expression because many are associated with developmental processes that
should be ending as the mouse approaches adulthood. For example, Islr2 is one of my
putative gene markers and it is already associated with axon guidance[26]. Since the
axons of Type I and Type II neurons are actively developing at age P1 when RNA
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sequencing was performed, then it makes sense to find expression of this type of gene.
However, the axons have fully matured by adulthood[24] so genes regulating functional
maintenance of the neuron, such as those for ion channels, would be expected in higher
numbers instead. The question as to whether there will be a difference in expression
between the two regions of the neocortex is an open one. It may be that different regions
have developmental gene cohorts that are unique to that region but this is a question that
has not been directly studied extensively. This could provide valuable insight into why
some mental disorders are associated with specific brain regions.
Recently, a powerful new approach to this issue, of determining new markers,
was developed which involves high-throughput neuronal subclass purification to obtain
population level RNA-sequencing data[17]. In other words, specific cell types are
isolated by tagging them using known markers and then sorted with flow cytometry.
RNA is then extracted from the resulting populations of cells, and RNA sequencing
performed on this material by reverse transcribing the mRNA to make a cDNA library,
and comparing that library to a reference genome. A reference genome is a previously
assembled sequence database used as a representative example of the desired species
genome. Reference genomes, such as Ensembl[27] or the UCSC genome[28], are
regularly updated to reflect current research including newly discovered genes or
correcting errors and misunderstandings from previous versions. All work on this project
used the Ensembl reference genome release 89[27].
This technique yields a dataset with many transcripts for each locus in the
genome, known as deep sequencing, that provides much higher quality for future
analysis. The dataset is then used to look for genes associated with this molecular
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program of differentiation. It also allows a new platform to assess whether the existing
cell types are valid or if subtypes exist within these groups. The gene expression data
files for this work, which can be found publicly available on the NCBI database, were
performed by Molyneaux et. al. (2015)[17].
In Molyneaux et. al. (2015), the authors examined the expression of three cell
types in the mouse primary somatosensory cortex at four different ages during
development E15, E16, E18 and P1[17]. The three cell types included the two cell types
mentioned of interest in our lab, Type I and Type II pyramidal neurons found in layer V
of the neocortex, as well as a layer VI corticothalamic neuron type which was not part of
the focus of this project. Only the data for Type I and II pyramidal neurons from P1 was
processed for the analysis of this project, as it coincides with the youngest age group for
our following IHC experiments.
The Molyneaux et. al. (2015) paper used a method for cell purification that they
had previously published which has become common practice in the field[3]. In this
paper specifically, they manually excised the primary somatosensory cortex of a litter of
mice (6-10 per litter) for each of eight replicates at the appropriate age[17]. The tissue
was then dissociated into a single-cellular suspension using papain and fixed with 4%
paraformaldehyde[17].
The single cell suspension was then immunostained with anti-CTIP2, anti-SATB2
and anti-TLE4 antibodies[17]. They used the differential expression of these three marker
antibodies to identify the three neuron types in their study. Type I neurons were identified
as having high CTIP2, low SATB2 and low TLE4 expression[17]. Type II neurons were
identified as having high SATB2, no CTIP2 and no TLE4 expression[17]. Whereas, layer
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VI pyramidal neurons have high TLE4, moderate CTIP2 and low SATB2 expression[17].
In this project, layer VI pyramidal neurons were excluded by cropping only layer V in the
regions of interest in the images.
The cells were then sorted via fluorescence activated cell sorting (FACS) based
on the differential staining for these antibodies between the three neuron types, where
each sample would be sorted for all three antibodies simultaneously[17]. Using these
antibodies to label the neurons comes with the caveat that it only labels a subset of each
neuron type. Therefore, the neurons identified hereafter as Type I neurons are those that
have high CTIP2, low SATB2 and (in the case of the Molyneaux dataset) low TLE4
expression[17]. Likewise, the neurons identified hereafter as Type II neurons are those
showing high SATB2, no CTIP2 and (in the case of the Molyneaux dataset) no TLE4
expression[17].
Using these three transcription factors together provides a reliable way to
positively discriminate between all three cell types, if admittedly a subset of each, and
was one of the biggest contributions of the Molyneaux et. al. (2015) paper[17]. Using
fluorogold injections (a retrograde tracer similar to the microbeads mentioned above) into
either the pons, contralateral cortex or the thalamus they were able to verify that the
antibodies were correctly staining the Type I, Type II and layer VI neurons,
respectively[17]. Also, as the goal of this analysis is to examine the most differentially
expressed genes between the cell types then any contamination of misidentified cells
should have a low overall effect on the sample.
The cell populations that they obtained were high quality with RNA integrity
numbers (RIN) ranging between 6.4 and 9 (median at 7.1) and obtaining approximately
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100,000 cells and 200 ng of total RNA per population[17]. This method of cell sorting
has been reproduced by many labs in the field and has proved a reliable alternative to
other methods such as retrogradely transported latex microbeads[3].
Image Analysis
Analyzing images that are the result of fluorescence microscopy can be a
challenge[23,29]. The amount of observed fluorescence is not directly quantifiable in
most cases but fluorescent intensities can be used for comparative studies[30]. Also, only
the presence of fluorophore can be measured, not the antigen itself, yet they should be
proportional. Even in properly controlled experiments there are many variables that can
have large effects on the level of observed staining; tissue preparation, quality of the
antibodies, time and temperature of incubation with antibodies[29]. These potential
pitfalls must be taken into account to mitigate their hazards.
These issues are compounded when analyzing images with multiple channels of
staining[31]. Direct comparison between absolute level of fluorescence of fluorophores
can be a fool’s errand, because one can never be sure that the differential intensities
reflect the biological reality of the objective amount of antigens. This is the problem at
the heart of colocalization analysis[31].
It is common in the literature for groups to merely show a micrograph with two or
more fluorophores and declare subjectively whether they are colocalizing[23,31–34]. A
common approach to aid this process is to selectively color fluorophores so that their
overlap in images produces a third color that is the additive sum of the two[31]. For
example, if different fluorophores are colored red and green, then colocalization of the
two would appear yellow to our eyes. A similar effect can be obtained with magenta and
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green, which produces white on overlap and has the added benefit of being readily
discernible even if the viewer is red-green colorblind. This crude method of
colocalization has the core limitation that large differences in intensity between channels
can underestimate the amount of observed colocalization as strong fluorescence in one
channel can effectively wash out the fluorescence of the other if it is sufficiently low[31].
Colocalization analysis can be broken down into two separate methods. First,
pixel-based methods, where the relative intensities of each channel is compared for every
pixel in the image[32]. This method is often easier to implement and understand
conceptually, because the output is a combination of correlation coefficients and easily
interpretable graphs. However, pixel-based methods are more sensitive to noisy images
and differential staining between fluorophores (such as one that localizes in the nucleus
and another that localizes in vesicles or the projections).
The second, object-based methods use object recognition algorithms to find
objects located in the plane of the image and makes all comparisons based on those
objects[35]. This is a more recent development and is often more technically difficult to
implement and understand conceptually because the correlation coefficients and output
graphs are more complicated to interpret. However, object-based methods offer more
robust results that are much less sensitive to noise and differential staining patterns.
In pixel-based methods, the relative intensity of each channel is extracted from
each pixel and a Pearson’s correlation coefficient along with Mander’s overlap
coefficients are calculated[32]. Pearson’s correlation results in a coefficient ranging from
-1 to 1. A coefficient of -1 corresponds to a negative correlation between fluorophores, or
complete avoidance of the fluorophores. A coefficient of 1 represents a positive
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correlation or complete colocalization of fluorophores. Mander’s coefficients, otherwise
known as overlap coefficients, quantify the incidence of one channel overlapping the
other and are calculated for each channel and range from 0 to 1. Therefore, an image
yielding the Mander’s coefficients of M1: 0.80 and M2: 0.20, would be interpreted as:
80% of pixels with

non-zero intensities in channel 1 also have non-zero intensities in

channel 2 and 20% of pixels with non-zero intensities in channel 2 also have non-zero
intensities in channel 1.
The other main output of pixel-based methods is a cytofluorogram, which
represent colocalization graphically[33]. The intensities of channel 1 are plotted against
the intensities of channel 2 on a standard scatterplot. Complete colocalization would
correspond to a solid straight line at 45° (Figure 1, D). Complete colocalization is a case
where the intensities in both channels are equal for every pixel. Complete avoidance
would correspond to two solid straight lines following each major axis independently
(Figure 1, F). Partial colocalization manifests as wide bands, vase shaped structures or
distinct groupings of data points (Figure 1, E).
Object-based colocalization methods utilize object finding algorithms similar to
those used in computer vision software to find objects of interests in an image[36]. Then
spatial analyses, such as Ripley’s K function, are used to determine colocalization.
Although this method is more difficult to implement and less commonly used, the results
are much more robust. These methods do not rely solely on the spatial relationship of the
location of the objects in the image as opposed to the pixel intensity data so are relatively
insensitive to noisy images, differences in fluorescence intensities and different staining
patterns. The user can also set size thresholds so that objects too small or large to be an
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intended target can be automatically excluded. The main output of this type of analysis is
a survey of objects that are either colocalized, in channel 1 only or in channel 2 only. The
output can therefore be represented as a ratio of colocalized to non-colocalized objects.

Figure 1: Sample cytofluorograms from pixel-based colocalization methods. (A-C)
Simulated fluorescence micrographs showing complete colocalization, partial
colocalization and avoidance. (D-F) The corresponding cytofluorograms for each
condition.
Computer Coding and Automation
This project involved a large amount of coding in various computer languages,
between the Neuroinformatics, image processing/analysis and statistical analysis. While
many of the methods utilized here could have been performed by a human, the sheer size
of datasets and the need for precision and reliability in data acquisition necessitated the
use of automation in several instances. Luckily, many of the programs available for
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processing large genetic datasets bear the brunt of this for the Neuroinformatics
methods[37]. This is not the case for image processing and analysis, especially when
batch processing several dozen images simultaneously.
When deciding whether to automate a process it is necessary to weigh the benefits
and costs of developing your own code. The process of development often requires a
large amount of streamlining and testing for verification[38]. The verification process
requires manual analysis on at least a small portion of raw data, to ensure that the code is
functioning correctly. Depending on how labor intensive the manual methodology is,
automation may be more labor intensive than manual analysis. However, when
automation works correctly the results can pay massive dividends. In the case of this
project the code more than made up for the effort that was saved from manual data
acquisition.
Reproducibility in science is another very important consideration[38–41]. For
example, obtaining the exact same data from manually counting cells in the microscopy
images would be nearly impossible since displacements in the locations of cells by just a
few pixels (an almost imperceptible shift to the human observer) may have a statistically
meaningful effect on the results depending on the situation. The same is true of the
bioinformatics analysis, there are so many permutations of the way that each analysis can
be run that it is important to keep a record of each command that is entered to ensure
reproducibility[37].
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CHAPTER II
NEUROINFORMATICS
Methods
Differential Expression
The dataset that this project is based on was a result of experiments performed by
the Arlotta lab out of Harvard University[17]. Their tissue was gathered from the primary
somatosensory cortex (SSp) at prenatal stages of development through postnatal day 1
(P1)[17]. Analysis of the Molyneaux[17] dataset began with collecting the data files from
the NCBI database. These files were downloaded to a Linux server (running Ubuntu
16.04.02 LTS).
The sequence read files were downloaded from NCBI as SRA files, eight Type I
neuron files and eight Type II neuron files (SRR1658922, SRR1658923, SRR1658928,
SRR1658929, SRR1658934, SRR1658935, SRR1658940, SRR1658941; and
SRR1658920, SRR1658921, SRR1658926, SRR1658927, SRR1658932, SRR1658933,
SRR1658938, SRR1658939 respectively). The Mus musculus Ensembl build GRCm38
reference genome and annotation files were downloaded from igenomes
(ftp://igenome:G3nom3s4u@ftp.illumina.com/Mus_musculus/Ensembl/GRCm38/Mus_
musculus_Ensembl_GRCm38.tar.gz on 5/01/17). The SRA files were converted to fastq
format with fastqdump (sratoolkit version 2.8.2-1).
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The tuxedo protocol[37] was followed using the public Galaxy server to perform
differential gene analysis (UseGalaxy.org version 17.01). Galaxy’s fastq groomer was
used to prepare the fastq files to make them more amenable to the Galaxy software
(Galaxy version 1.0.4). The sequences were aligned to the reference genome with
TopHat2 (Galaxy version 2.1.0), all settings left as default. The aligned transcripts were
assembled with Cufflinks (Galaxy version 2.2.1.0), all settings left as default, except bias
correction set to yes. Cuffmerge was used to combine the resulting assemblies together
into a parsimonious transcriptome (Galaxy version 2.2.1.0), all settings left as default.
The differential analysis is performed with Cuffdiff (Galaxy version 2.2.1.3), all settings
left as default, except bias correction set to yes. For my design, it identified over 5000
differentially expressed genes when comparing Type I and Type II neurons.
The workflow designed for this analysis was saved for reproducibility and for use
in future experiments. A graphical representation was downloaded directly from the
websites user interface (Appendix B). The workflow can also be downloaded as a file and
loaded into other profiles or instances of Galaxy so other users can follow the exact same
protocol. The workflow was published in the UseGalaxy.org published workflow section
(https://usegalaxy.org/u/bioryguy/w/copy-of-moly-redo) and is available via search at the
website.
Physiological Relevance
The output from Cufflinks was then processed with AltAnalyze v2.1.0
(http://AltAnalyze.org/)[42]. AltAnalyze is a software application designed for analysis
of alternative splicing-sensitive platforms such as RNA-seq and microarray. Importantly,
it also allows for the identification of biologically relevant gene clusters. The program
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can determine, for example, that genes associated with axon guidance are elevated in a
target population, as they are in these two cell populations. These GO-Elite[43] pathways
are useful for developing an idea of clusters of differentially expressed genes and gives
some insight into how they may be interacting with each other.
AltAnalyze also outputs some useful analyses for quality control such as lineage
profiling analysis. Lineage profiling produces both tissue fate maps for each of the
selected cell types (in this case one each for Type I and Type II), and a heat map
visualization with hierarchical clustering. The tissue fate maps provide an idea of which
types of tissues are most similar to your experimental groups and highlights those groups
on a tissue lineage network map[42]. The heat map visualization provides a hierarchical
clustered list of tissue types that are most and least similar to each of your experimental
groups.
AltAnalyze was set to process RNA-seq aligned read counts from junction BED
files with a moderated t-test and using default parameters. The same Ensembl database
(Mus musculus Ensembl build GRCm38) was downloaded through the AltAnalyze user
interface to match the reference database for the Cufflinks dataset. Options to predict
biomarkers, perform lineage profiling and to analyze ontologies and pathways with GOElite were selected to run. ASPIRE was left as the default alternative exon finding
algorithm.
The output of AltAnalyze was also loaded into Excel to identify targets for
Hypothesis 2. Approximately 5000 differentially expressed genes were analyzed to try to
determine good candidates for cell type specific markers. Since AltAnalyze performs its
own statistical analyses of the differential expression patterns, all of the genes with a
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p-value greater than 0.05 were removed as non-significant. The remaining genes were
then sorted by the level of differential expression, as the genes with the highest difference
in expression were the most likely to be cell type specific markers.
Gene expression levels are presented in units of FPKM (Fragments per kilobase
of transcript per million mapped reads), and the differential expression is often quantified
as a base 2 logarithm. The level of expression varies in the database from a maximum of
6,292 FPKM to a minimum of 0.03851 FPKM with a median of 15.25 FPKM. The genes
identified were chosen as candidate markers because they were all above the median
expression (15 FPKM), in at least one of the cell types, and with a differential expression
of log2(<4) which corresponds to a minimum 16-fold difference. These criteria were
chosen because they provided a reasonable size to the list of candidate genes (fourteen);
for example, using a lower differential expression threshold of log2(3) yielded a candidate
list of 294 genes.
Genes with a low overall expression level (<15 FPKM) would be avoided even if
they were highly different in expression levels. The rationale behind this is that even if
two genes have approximately the same relative differential expression, the gene with
higher absolute levels of expression is a better candidate from the standpoint of easier
identification with immunohistochemistry. In other words, if there are higher levels of
protein expression then there are more target epitopes for antibodies. It was assumed that
mRNA expression levels correlate positively with protein expression levels, however it is
worth noting that this is not necessarily the case.
For verification of the results from AltAnalyze, the output of Cufflinks was also
processed in the Database for Annotation, Visualization and Integrated Discovery
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(DAVID v6.8; https://david.ncifcrf.gov/), which performs similar functions of
determining biological relevance of genes[44]. Domain Graph v3.01 was used to
visualize biologically relevant gene clusters[42].
Results
Fourteen genes in our dataset met the above criteria (statistically significant
differential expression, differential expression > log2(4), and overall expression > 15
FPKM), seven Type I and seven Type II putative gene markers (Table 1 and Table 2
respectively). Note that one of the most differentially expressed genes in the dataset is
Ctip2, the established Type I marker. Satb2, the established Type II marker, is also in the
dataset and narrowly missed the short list. All the putative type markers were also
identified as predicted biomarkers by AltAnalyze.
Table 1: Putative Type I marker genes
Gene ID
Crym
Tcerg1l
Npr3
Kif26a
Ctip2
Islr2
Pcp4

Diff. Expression
(log2)
6.91
6.23
5.83
5.74
5.66
4.22
4.92

Type I Expression
(FPKM)
48.6
90.5
15.6
136
117
448
57.4

Type II Expression
(FPKM)
0.404
1.21
0.256
2.53
2.31
24.0
1.90

Table 2: Putative Type II marker genes
Gene ID
Inhba
Fn1
Cux2
Plxna4
Lhx2
Shisa2
Ntng2

Diff. Expression
(log2)
-6.27
-5.94
-5.34
-4.64
-4.37
-4.36
-4.08

Type I Expression
(FPKM)
0.235
0.908
2.61
2.74
7.26
1.01
13.4

Type II Expression
(FPKM)
18.1
55.8
105.6
68.6
151
20.8
227
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A literature search reveals some very important points about these genes of
interest. First, is that most of these genes are so far unassociated with the neurons that are
the subject of this study. Some are associated with these neuron types in other ages or
brain regions, but only Ctip2 has ever been observed before in both these ages (P1, P7)
and brain regions (mPFC, SSp)[3]. Second, is that several of them are associated with
physiological processes that are known to be active in these neurons at this stage of
development, such as axonal guidance (notably Islr2, Plxna4 and Ntng2)[13,26,45].
Third, is that several of these genes are known to be transcription factors (Crym, Tcerg1l,
Ctip2 and Lhx2)[3,46–48], which are important because they will then drive the
expression of other genes downstream, i.e. constituting gene networks that may control
global expression of layer V appropriate properties. Likewise, Cux2 contains a homeobox
DNA binding domain, so it may be a transcription factor as well[49]. Fourth, the
physiological roles of these genes are unknown for almost all of these genes in the
neurons of interest of this study, so until functional studies are performed on each gene
individually their roles are speculative. Last, is that several of these genes are also
associated, via genome-wide association studies, with neurological disorders. Some of
these disorders are also associated with either Layer V pyramidal neurons or the medial
prefrontal cortex; such as ADHD (Tcerg1l)[50], Autism (Pcp4)[51], Epilepsy and
Schizophrenia (Fn1)[52,53] or Parkinson’s disease (Plxna4)[45]. This might have clinical
significance as these genes or their proteins may be viable targets for treatment in these
disorders.
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The following summarizes the significance of each of these genes within the
literature. Mu-crystallin (Crym, or NADP-regulated Thyroid-hormone-binding protein) is
a transcription factor with a direct role in gene transactivation mediated by the thyroid
hormone T3 [54]. More importantly, this gene is already associated with neuronal
differentiation in Layer 5 pyramidal neurons of the primary somatosensory cortex[3].
This gene has the highest differential expression of the markers for Type I neurons in this
analysis.
Recent studies show that Transcription elongation regulator 1-like (Tcerg1l) is
expressed in Type I neurons of the primary visual cortex of adult mice[55]. Expression is
also increased in gross tissue sections of the macaque prefrontal cortex[47]. Tcerg1l is
also associated with ADHD in human patients[50].
There is little relevant information in the literature for Natriuretic peptide
receptor 3 (Npr3), but it has recently been associated with axonal branching in dorsal
root ganglion neurons of the mouse spinal cord[56]. Kinesin family member 26A (Kif26a)
encodes an atypical kinesin that is associated with enteric neuronal development[57].
Of all the putative markers identified here, Coup-TF-interacting protein 2
(CTIP2, or Bcl11b), is the only one with a well-documented role in the development of
Type I or II neurons in the literature. It is one of the best known markers of Type I
neurons[3]. Ctip2 acts to guide the axons of Type I neurons to targets outside of the
neocortex, such as the brain stem[10]. Knockouts of this gene spontaneously abort just
before birth, and completely lack Layer V neurons with corticofugal axons[58].
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Immunoglobulin superfamily containing leucine-rich repeat 2 (Islr2) is required
for axon extension at the optic chiasm during neural development of retinal ganglion cells
in vertebrates[26]. Islr2 is the most highly expressed transcript in Type I neurons.
Purkinje cell protein 4 (Pcp4) codes for a small calmodulin binding protein, and
is highly expressed in Type I neurons. Pcp4 is documented in corticospinal motor
neurons of the sensorimotor cortex and visual cortex of the mouse[3] and its altered
expression in the dorsolateral prefrontal cortex is associated with autism in human
patients[51].
Inhibin beta A (Inhba) is expressed in Type II neurons of the adult mouse
somatosensory cortex[59]. This gene is the most differentially expressed Type II marker
in our analysis, but has a moderate overall expression level. Fibronectin 1 (Fn1), codes
for a cell adhesion extracellular matrix protein, is involved in the development of
tecto-thalamic projection neurons in the tectum (a structure in the mid-brain that
processes auditory and visual reflexes) of the rat[60]. It is also associated with both
epilepsy and schizophrenia in humans[52,53].
Cut-like homeobox 2 (Cux2), like Inhba, is expressed in Type II neurons of the
adult mouse somatosensory cortex[59]. However, at later ages Cux2 is more highly
expressed in more superficial layer neurons (layer 2/3 and layer 4) and is speculated to be
a transcription factor[55]. These lines of evidence suggest that the expression of this gene
varies widely within cell types over maturation of the animal.
Plexins are a class of membrane receptors for semaphorins and are well known in
directing neuronal dendrites and axons[59] as is Plexin A4 (Plxna4). The PLXNA4
protein specifically acts by inducing axonal growth cone collapse upon binding with the
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semaphorin, SEMA3A[61]. This gene is also associated with Parkinson’s disease in
humans[45]. LIM/homeobox 2 (Lhx2) is expressed in Type II neurons postnatally in the
mouse primary somatosensory cortex[62].
There is also little in the literature about Shisa homolog 2 (Shisa2) involving mice
or even mammals. It is an inhibitor of WNT and FGF signaling pathways in Xenopus,
and appears to be enriched in murine in vitro embryonic stem cell cultures lacking
retinoic acid, which is itself associated with neural differentiation[63].
By contrast, there is much more information about Netrin G2 (Ntng2). The Netrin
family of proteins is a large protein family that is generally associated with outgrowth of
neuronal projections[64]. Ntng2 is involved in controlling neuronal projection patterning
within specific lamina[13] and regulates synapse development[65] in the mouse
hippocampus. Its expression has also been observed in Type II neurons of the mouse
primary somatosensory cortex, like some of the other genes on this list[17]. This gene
also had the highest expression of all the putative Type II cell markers in this analysis.
The lineage profiling analysis and GO-Elite pathway analysis both produced
similar results. Associations with neural development were identified with both
methodologies. The lineage profiling identified closely related tissues for both cell types
such as brain and fetal spinal cord. The highest correlation was seen with neural
progenitors and visual cortex. Interestingly, neither prefrontal cortex nor somatosensory
cortex were highlighted.
Ontology analysis showed that the two cell types are indeed very similar in the
types of genes expressed as evidenced by the similarities in Z-scores. Both cell types
were most highly correlated with cell types associated with neurons, development or both
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(fetal spinal cord, visual cortex, neural progenitor, neurons, dopaminergic progenitor,
brain). Interestingly, they also expressed genes associated with the endoderm (endoderm
and endoderm progenitor), even though they are derived from the ectoderm, as well as
other seemingly dissimilar cell types such as bone type cells (megakaryocytes, bone
marrow hematopoietic cells, erythroblast progenitors) and cardiac tissue (early and late
cardiac progenitors, cardiac progenitors). Finally, where they differ offers some
interesting comparisons. For example, Type II neurons showed slightly positive
associations for Cardiac fibroblast progenitors as well as Thymus cells and Endoderm
progenitors where Type I neurons showed negative associations for those tissues.
The results of the lineage profiling analysis and GO-elite pathway analysis,
perhaps more than anything, verify the reliability of the rest of the output from
AltAnalyze. If there were very unusual results coming from these lines of evidence it
would suggest problems with the reliability of the results, but for the most part these
results are as expected, the neurons resemble the tissue that they derive from and are very
similar to each other with notable exceptions.
Looking at the network diagrams can help highlight why some of these other cell
types are resulting from the lineage profiling and ontology analysis. Both Ctip2 and Satb2
were present in the Regulated Gene Network as were the putative type markers, Ctip2
(Bcl11b), Satb2, Inhba and Lhx2 (Figure 2). Many genes up-regulated in Type I neurons
were associated with the Nervous system or Neurological phenotype (Figure 3). Several
of the Type I putative markers were also reflected in this network (Ctip2, Crym, Islr2,
Pcp4 and Kif26a).
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Figure 2: Regulated gene network. Blue gene nodes are associated with Type I neurons;
red gene nodes are associated with Type II neurons. Lines between nodes indicate
positive association in the literature. Arrows between nodes represent positive regulation
on the target of the arrow. Highlighted genes are those identified as genes of interest in
this study; Green = Ctip2 (Bcl11b) and Satb2, yellow are putative markers.
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Figure 3: Genes up-regulated in Type I neurons. The two square nodes in the center
represent gene ontology phenotypes, nervous system and behavior/neurological
phenotypes are present here. The arrows pointing from each gene node indicate active
regulation of the arrows target. Highlighted genes are those identified as my genes of
interest; Green = Ctip2 (Bcl11b), yellow are putative markers. Pcp4 and Islr2 are
associated with both phenotypes.
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Figure 4: Genes up-regulated in Type II neurons. The two square nodes in the center of
each cluster represent gene ontology phenotypes, transcription regulator and receptor
phenotypes are present here. The arrows pointing from each gene node indicate active
regulation of the arrows target. Highlighted genes are those identified as my genes of
interest; Green = Satb2, yellow are putative markers.
Many of the genes up-regulated in Type II neurons were associated with
Transcription regulation (Figure 4) as well as receptors, including Eph receptors which
are involved in axon guidance of the developing neuron. Likewise, many of the Type II
putative markers were in this network (Satb2, Lhx2 and Cux2). Nr4a2 is associated with
both phenotypes. Several of the receptors are Eph receptors (Epha3, Epha4 and Ephb6), a
class of receptors known to be involved in axon guidance of developing neurons.
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Figure 5: CTDOntology Disease phenotypes associated with each neuron type. Blue gene
nodes are associated with Type I neurons; red gene nodes are associated with Type II
neurons. The square nodes represent various disease phenotypes, several of which
produce neocortical function disabilities (Schizophrenia, Autism and Brain Ischemia).
The arrows pointing from each gene node indicate active regulation of the arrows target.
The highlighted gene (Cav1) is one of those identified as a gene of interest.
The Comparative toxicogenomics database (CTD) is an annotated database of
disease phenotypes and interactions between chemicals, gene products and their
relationship to those disease phenotypes[66]. The CTD ontology network (Figure 5)
displays some of the disease phenotypes associated with the differentially expressed
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genes in this analysis. Schizophrenia and Autism are neurodevelopmental
disorders[67,51] so it is no surprise to see them in the network.
Gene clusters associated with axon guidance, a defining characteristic between
the two cell types, were present in both the up-regulated and down-regulated gene
networks. Another interesting result is the lack of some of the genes of interest (Tcerg1l,
Shisa2 and Ntng2) from the network diagrams. The networks represent those gene
interactions that are documented in the literature[42], so the lack of some putative
markers may be highlighting what little is known about those genes that are absent from
the diagrams. That also affords an opportunity for future research into the function and
interaction of these genes.
Table 3: Top ten gene ontology terms. Results from GO-Elite analysis sorted by Z-score.
Ontology Name
(Ontology-ID)
1. Negative regulation of axon regeneration
2. Neuron projection (GO:0043005)

Changed

Ontology

Z-Score

5
557

Changed
(%)
80
9.69

11.1
11.0

Fisher
Exact-P
1.90E-06
1.51E-17

4
54

3. Developmental process (GO:0032502)

176

3463

5.08

10.6

9.96E-22

4. Regulation of cell projection size
(GO:0032536)
5. Protein binding (GO:0005515)

4

6

66.7

10.1

5.57E-06

354

9544

3.71

9.97

4.17E-23

6. Extracellular matrix (GO:0031012)

36

338

10.7

9.67

2.74E-13

7. Neuronal cell body (GO:0043025)

35

323

10.8

9.66

3.56E-13

8. Synapse (GO:0045202)

37

365

10.1

9.42

5.79E-13

9. FACIT collagen (GO:0005593)

3

4

75

9.29

6.10E-05

10. Cell adhesion (GO:0007155)

52

637

8.16

9.29

7.11E-14

In general, AltAnalyze showed an increase in gene networks associated with
Neuronal differentiation and development. GO-Elite analysis yielded 70 statistically
significant gene ontology terms (Table 3, top ten). Several gene terms associated with
development and neurons were present in the top ten alone. Of particular importance is
that four of the top ten terms (1, 2, 4 and 8) are associated specifically with projections of
the cell types which is consistent with the gene networks. DAVID functional annotation
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clustering with the top 100 most differentially expressed genes yielded similar results
with many gene clusters related to Neural development, Neurogenesis, Cell proliferation
and Regulation of transcription.
Fourteen putative type markers were identified by this analysis, many of which
are undocumented in the literature in these neurons, brain regions and ages. Furthermore,
the functional relevancy of the genes and gene clusters identified are indicative of the
physiological, morphological and hodological differences seen between type I and II
neurons. The targeting of the axons of these neurons is the defining feature between the
two types and every line of evidence shows that genes associated with these processes are
differentially regulated. Bringing these genomic techniques into the lab allows the use of
these same methods on older mice, up to adulthood, in the future to better understand the
maturation of these neurons.
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CHAPTER III
COLOCALIZATION ANALYSIS
Methods
Fluorescence Immunohistochemistry
After the identification of targets from Research question 1, antibodies for the
corresponding protein products were purchased to characterize protein expression with
fluorescence immunohistochemistry. The genes identified were based on data from the
primary somatosensory cortex of a mouse at postnatal day 1 (P1), however the antibodies
were used to determine the expression of these proteins in the medial prefrontal cortex in
addition to the primary somatosensory cortex in mice at ages P1 and P7. The decision to
extend this experiments out to age P7 is part of future plans to extend the genomic
analysis described in the previous chapter out to adulthood in the mouse, as many of the
work up to know involves predominantly prenatal mice ages.
All procedures used throughout this research project were in accordance with the
University of Northern Colorado Institutional Animal Care and Use Committee protocol
1606D-MT-M-19 (Appendix A). C57bl/6 mice of both sexes were used in this research.
All animals were housed 2-4 animals per cage with a 12:12 light/dark cycle, on-site at the
University animal facility and were provided ad libitum access to food and water.
All animals were rendered deeply unconscious with CO2 asphyxiation then
sacrificed by rapid decapitation. The brain was immediately removed, followed by
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cleansing washes in 1X phosphate buffered saline (PBS) and overnight fixation in 4%
paraformaldehyde (PFA) at 4°C. Some tissue samples were fixed in 95% ethanol, if
previous paraformaldehyde fixed experiments yielded negative results. However, ethanol
fixation did not result in successful experiments in any of these tissue samples. The brain
was then submerged for two to three days in 20% sucrose at 4°C as a cryoprotectant for
snap freezing on liquid nitrogen with 2-methylbutane as a freezing medium. The tissue
was stored in a -80°C freezer until cryosectioning.
Coordinates for the two regions of interest were obtained from a Developmental
mouse brain reference atlas for both ages[68]. Tissue for the medial prefrontal cortex
(mPFC) at age P1 was collected 500-800 µm posterior to the rostral tip of the cerebral
hemispheres; primary somatosensory cortex (SSp) was collected 1000-1300 µm posterior
to the rostral tip. At age P7 medial prefrontal coordinates were 500-1000 µm, and
primary somatosensory cortex coordinates were 1000-1800 µm. Coronal sections at 30
µm in thickness were obtained on a cryostat at -15°C cabinet temperature, -10°C for the
specimen holder. The tissue sections were thaw-mounted[69] on a cleaned and poly-Dlysine coated[70] microscope slide with 10 to 12 tissue samples per slide. The slides were
left on a slide warmer at 37°C for 30 minutes to aid in tissue adhesion to the slide.
Primary and secondary antibodies were diluted in 0.2% Triton x100 in phosphate
buffered saline (PBS). The sections were washed three times in PBS for 20 minutes at
room temperature then submerged overnight in the primary antibodies in appropriate
concentration (Table 4). The primary antibodies were then removed and replaced with
secondary antibodies matched to the type of primaries for one to two hours. Removal of
the secondary antibodies were followed by three rinses in PBS for 20 minutes at room
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temperature, followed by nuclear counterstaining with Hoechst 33342, which generally
stains adenine-thymine rich sequences of the minor groove of double stranded DNA[71],
for 5 minutes at room temperature. Then a last rinse in PBS for 20 minutes at room
temperature.
Primary antibodies were selected carefully to avoid using antibodies raised in the
same species for colocalization experiments. Some antibodies came with a manufacturers
recommendation for heat mediated epitope retrieval. For those antibodies, the tissue was
submerged in a Sodium Citrate buffer solution (10mM Sodium Citrate, 0.05% Tween 20,
pH 6.0) for 40 minutes at 95°C. Secondary antibodies were carefully selected in these
experiments to avoid overlap of absorption/emission spectra of conjugated fluorophores.
After this process, the success of the experiment was confirmed on an inverted
fluorescent microscope and the sections were permanently mounted with 50% sucrose in
PBS and the coverslip adhered with clear nail polish.
The staining of four novel putative markers of each neuron type were assessed for
a total of eight proteins. Many (6) of the putative marker antibodies showed no staining in
the target tissue whatsoever, despite best efforts at optimization or epitope retrieval.
Methods of optimization included variation in concentration, time and temperature of
incubation, different primary and secondary combinations, tissue preparation and fixation
methods, and both temperature and enzyme mediated epitope retrieval. The ramifications
of these failed experiments are explored in depth in the conclusions chapter, but they
were not used for the final round of experiments. Only PCP4 and TCERG1L (both Type I
markers) showed positive staining patterns, and TCERG1L only weakly after epitope
retrieval.
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Table 4: Antibodies list
Antigen

Species

Type

HIER

Dilutions
AFgM
AFgRb

1°Ab
Cy5R
CTIP2
R
IgG2a mAb No
1:250
1:100
SATB2
M
IgG1 mAb
No
1:100
1:200
PCP4
Rb
IgG pAb
No
1:100
1:200
TCERG1L
Rb
IgG pAb
Yes
1:10
1:200
CRYM
Rb
IgG pAb
No
1:250
1:200
CRYM
M
IgG1 mAb
No
1:200
1:200
MDGA1
Rb
IgG pAb
Yes
1:250
1:200
INHBA
Rb
IgG pAb
Yes
1:100
1:200
NTNG2
M
IgG2b mAb No
1:200
1:200
CUX2
Rb
IgG pAb
No
1:200
1:200
Abbreviations: AFgM, Alexa Fluor goat anti-mouse secondary antibody; AFgRb, Alexa
Fluor goat anti-rabbit secondary antibody; Cy5R, Cy5 goat anti-rat secondary antibody;
HIER, Heat induced epitope retrieval; IgG, immunoglobulin G; M, mouse; mAb,
monoclonal antibody; pAb, polyclonal antibody; 1°Ab, primary antibody; R, rat; Rb,
rabbit; Species, host species. All primary antibodies were purchased from Abcam, Alexa
Fluor secondary antibodies were purchased from Molecular Probes, Cy5 secondary was
received from Dr. Judith L. Leatherman.
CTIP2 is well established in the literature as a Type I marker, and SATB2 is a
well-established Type II marker[3,9,16,17]. The RNA-seq dataset used CTIP2 and
SATB2 to determine cell type[17] so we maintain consistency in neuronal identification
between our study and theirs. Therefore, the combination of a high level of CTIP2 with a
low to moderate level of SATB2 staining can be used as a positive identification of Type
I neurons, whereas high levels of SATB2 staining and negative to low levels of CTIP2
staining can be used as positive identification of Type II neurons[17]. Their establishment
in the literature as markers also makes them uniquely suited for use as positive controls.
Co-staining with these established markers was crucial to the proper identification of
neuron type in these mice where other methods such as retrograde labelling was not
feasible at these ages in our lab until recently. Due to the potential simultaneous use of
CTIP2 and SATB2 antibodies with another putative marker, the antibodies were carefully
selected for host species to avoid overlap of secondary binding.
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A final round of four-channel fluorescent photomicrographs was obtained on a
Zeiss LSM 700 confocal microscope for image analysis. Four-channel experiments were
important to provide a better basis for comparison between the putative type marker
(PCP4 or TCERG1L) and both established type markers (CTIP2 and SATB2) in the same
tissue sample, in addition to the Hoechst DNA stain to show nuclear positions. In order to
obtain subcellular image resolution but still retain the ability to observe the entire region
of interest, tile scan images were obtained with image stitching performed by the onboard
proprietary Zeiss Zen software package. Each tile scan image consisted of seven rows
and five columns of stitched images taken with bidirectional scanning. All images were
obtained with a 40x C-Apochromat, 1.2 NA, water immersion lens. Digital images were
captured with a resolution of 1024 x 1024 pixels, 1.27 µsec pixel dwell time, averaging
set at 2 and 12-bit color depth. The pinhole diameter for each channel was set to 0.99
Airy units for image capture.
Image Analysis
The images were processed in FIJI v.1.51[72], a distribution of ImageJ, and
Icy v1.8.6.0[40] to determine the extent of colocalization in the target tissue. Both are
open-source photo analysis programs. Since there were a large number (n = 87) of final
images, each with dozens to hundreds of individual cells to be counted and individually
assessed for colocalization, custom scripts and macros were used extensively to aid in
automation. Although this resulted in a large investment of time and effort in
development and optimization of custom code (Appendices C-H), it drastically decreased
the final processing time.
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The image analysis was performed largely in four separate steps: image
correction, pixel-based colocalization, object-based colocalization and statistical analysis.
Part of the first step, as well as the second and third steps in their entirety, were coupled
together with a custom script that uses human-in-the-loop principles to utilize the
strengths of both users and computers (Appendix C). Automated methods were verified
for accuracy via comparison with manual cell counts on 32 of the final 87 images.
Another benefit of this investment is greater reproducibility as well as a decrease in
human bias and error.
Image correction. To aid in visualization, each four-channel image was split into
three separate three-channel images using a custom protocol in the Icy graphical
programming plugin Protocols (Appendix D). All three images have the Hoechst channel
to help outline the tissue histology. One resulting image has the CTIP2 and SATB2
channels for use as a control. One compares the CTIP2 channel in addition to the putative
marker (PCP4 or TCERG1L) for that experiment, denoted as the Type I experimental
group. The last image compares SATB2 in addition to the same putative type marker,
denoted as the Type II experimental group.
Colocalization analysis is very sensitive to static and background staining[23,34].
This was particularly true with TCERG1L as there was low overall positive staining and
a moderate amount of background (i.e. poor signal to noise ratio). One common way of
minimizing this problem is by thresholding each channel[23]. In this case, the images
were cleaned up with a modification of a complex masking threshold procedure found in
the documentation for ImageJ (http://imagej.net/Image_Intensity_Processing). A script
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automating the process was written as well as another making it suitable for batch
processing of files (Appendix E).
Pixel-based colocalization. In Pixel-based colocalization analysis the relative
intensities of each channel are extracted from each pixel for statistical comparison.
Pixel-based colocalization was performed both with a custom written script (Appendix F)
and with the Just Another Colocalization Plugin (JACoP)[23] for FIJI. The custom script
extracts the intensity data from each pixel and places it in a dataset which allows the
construction of fluorograms to assess colocalization. Since JACoP is professionally
developed, it has a large amount of powerful features as well as a strong following in the
literature[31,34,35]. Pearson’s and Manders’ coefficients were selected to be displayed in
the log file so that they could be automatically retrieved later with a batch script.
Object-based colocalization. Object-based methods utilize basic object finding
algorithms to identify cells (or other objects of interest) within the image then uses spatial
analysis to determine colocalization[30,36]. Object-based methods were used both for
comparison to the pixel-based methodology but also because it often provides more
robust results that are less sensitive to noise, differing staining patterns or brightness
between comparison channels[36]. The minimum allowed object size was 500 pixels and
the maximum was 8000 pixels which helped to reduce the influence of artefactual
staining of extracellular structures and blood vessels. Defaults were used for all other
settings.
Manual cell counts were performed on 37% (32 of 87) of the images for
verification of the automated cell counts obtained from the object-based analysis. Manual
counts were performed by one expert researcher with the use of manual counting aids in
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Icy[40]. Coordinate location and number of detections was saved as sequence
information for each image. Automated cell counts were obtained from the output of
JACoP.
Statistical analysis. All statistical analyses and data manipulation were run in
RStudio v0.99.902. A custom data management script was written to extract the data
from the text output log files of the Colocalization protocol and compiles the dataset in a
csv file. A Fisher’s exact test was run for each image individually and a Pearson’s Chisquared goodness-of-fit test was used to determine whether there was a significant
difference overall between the manual and automated cell counts (Appendix G). Once the
automated cell counts were verified statistically they were compiled into a master dataset
for all subsequent analyses (Appendix H).
Multiple linear regression with stepwise variable elimination was used to create a
model for each putative type marker (one for PCP4 and one for TCERG1L) which took
age, brain region (mPFC vs. SSp) and marker type as independent variables and
colocalized proportion as the dependent variable. An ANOVA test was then run on the
linear model and a Tukey HSD post-hoc test performed pairwise comparisons. Power
analysis was run to help determine an appropriate sample size of images needed to
properly detect the expected effect size for a given level of confidence. Two age groups
and two brain regions left a total of four groups per experiment. I used standard
significance level (α=0.05), power (1-β=0.8) and effect size estimates (Cohen’s d=0.40).
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Results
Fluorescence Immunohistochemistry
Of the antibodies purchased for the putative type markers, only PCP4 and
TCERG1L showed positive staining patterns in IHC experiments. Those antibodies were
then used for subsequent four-channel experiments with both CTIP2, SATB2 and
Hoechst stain. Photomicrographs for both PCP4 and TCERG1L were taken for both brain
regions of interest (mPFC and SSp) and both ages of interest (P1 and P7).
Both of the putative markers were predicted to be Type I markers so they were
expected to colocalize more with CTIP2 than SATB2. Furthermore, because the dataset
was collected from P1 mice in the primary somatosensory cortex; it was expected that
they would colocalize most in the primary somatosensory cortex at age P1 and less so in
the medial prefrontal cortex and less in general at age P7. Indeed, the imaging for PCP4
(Figure 6) supports that first prediction at both age groups, PCP4 clearly colocalizes with
CTIP2 much more often than SATB2. However, it was not visually obvious that
colocalization is higher in the P1 mouse than the P7 mouse; or in the primary
somatosensory cortex over the medial prefrontal cortex. Ultimately the difference
between brain regions and age groups were not statistically significant.

Figure 6: Colocalization of CTIP2 and SATB2 with PCP4. Neurons that are strongly colocalized will appear more white with this
colorization scheme. (A, D, G, J) CTIP2, a Type I marker, and SATB2, a Type II marker, show that the neuron populations are mostly
isolated in their expression of these markers. However, there is some overlap. (B, E, H, K) CTIP2 and PCP4 were predicted to have a
high level of colocalization with the highest expected in pane H. (C, F, I, L) SATB2 and PCP4 were predicted to have a low level of
colocalization. Overall staining patterns were much as expected.
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Figure 7: Colocalization of CTIP2 and SATB2 with TCERG1L. Neurons that are strongly colocalized will appear more white with this
colorization scheme. (A, D, G, J) CTIP2, a Type I marker, and SATB2, a Type II marker, show that the neuron populations are mostly
isolated in their expression of these markers. However, there is some overlap. (B, E, H, K) CTIP2 and TCERG1L were predicted to
have a high level of colocalization with the highest expected in pane H. (C, F, I, L) SATB2 and TCERG1L were predicted to have a
low level of colocalization. Overall staining patterns did not match predictions well.
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TCERG1L was predicted to have similar staining patterns to CTIP2 and PCP4,
however the imaging does not support that hypothesis (Figure 7). Overall staining with
TCERG1L was low, which contributed to a large amount of background artifact. No
discernible positive staining was observed in the medial prefrontal cortex at age P1.
However positive staining was observed in the primary somatosensory cortex at P1 and
in both regions at age P7. This suggests temporal differences in the development of these
two regions. The neurons that are TCERG1L+ are not reliably CTIP2+ or SATB2+ in
either age group or tissue type (Figure 7, A-L).
The different patterns of staining are also important to mention. CTIP2 and
SATB2 are known to be transcription factors and to bind in the nucleus of the cell, CTIP2
binds the DNA directly and SATB2 binds to CTIP2 acting as a repressor[16]. The
nuclear staining patterns of CTIP2 and SATB2 is exactly what is seen here. TCERG1L
also appeared to have a nuclear staining pattern, but the staining pattern of PCP4 seems to
outline the soma of the neuron in a perinuclear pattern and even reaching down into the
base of the axon (Figure 6). This difference in staining patterns between CTIP2 and PCP4
is more pronounced by age P7 (Figure 6; E, F, K and L). This is important because the
success of pixel-based colocalization methods require very close overlap as well as
similar staining patterns to be effective. Even though the two proteins are clearly
occurring in the same neurons, the pixel data will not show that colocalization because
they are physically sequestered within separate cellular compartments.
Image Analysis
Pixel-based methods were not diagnostic. The results for the pixel-based
analysis were not informative in this case and display some of the limitations of the
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method (sensitivity to noise and different staining patterns). The fluorograms for both
PCP4 and TCERG1L experiments show no clear difference between any of the
experimental groups (Figure 8 and Figure 9). These results do not reflect the images
obtained for PCP4, where there are clear visual differences between groups. Perfect
colocalization would show a solid yellow line corresponding to x=y, which is similar to
the trend that would be expected for the CTIP2/PCP4 comparison (Figure 8, B and H). In
the case of avoidance, a complete lack of colocalization, the fluorograms would have two
separate lines settled along the vertical and horizontal axes, expected in the
CTIP2/SATB2 and SATB2/PCP4 comparisons (Figure 8; A, C, G and I). Instead of
either of those states most of the fluorograms display fan shaped structures without much
difference between groups that should display very different structures. The images for
TCERG1L did not show any obvious or reliable colocalization anywhere. So the fan
shapes displayed in the fluorograms (Figure 9) are consistent with the photomicrographs
(Figure 7), however, this does not agree with the prediction, from Hypothesis 2, that
TCERG1L would colocalize with CTIP2.

Figure 8: Fluorograms for PCP4 experimental groups. Perfect colocalization would show a solid yellow line with a slope of 1.
Avoidance would be two separate lines falling roughly along the horizontal and vertical axes. These fluorograms do not indicate any
consistent relationships between groups, which does not appear to reflect the relationships observed in the photomicrographs.
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Figure 9: Fluorograms for TCERG1L experimental groups. Perfect colocalization would show a solid yellow line with a slope of 1.
Avoidance would be two separate lines falling roughly along the horizontal and vertical axes. These fluorograms do not indicate any
consistent relationships between groups.
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One concern is that the Pixel Intensities script (Appendix F) might not extract
valid data from the images. However, the JACoP plugin also produces a dataset that can
be analyzed by the same code to create a fluorogram for comparison between the two.
The corresponding fluorogram pairs are visually identical (Figure 10).

Figure 10: Pixel intensities code compared to JACoP. The output of the custom written
code (A, B, C) compared to the output of JACoP (D, E, F) are virtually identical.
Another perhaps more useful output of Pixel-based analysis is Pearson’s and
Manders’ correlation coefficients. However, those results were also inconclusive and
showed no difference between groups (Table 5 and Table 6). Following Hypothesis 2,
similar Pearson’s and Manders’ Coefficients were expected between the control and Type
II comparisons. Higher coefficients were also expected for the Type I comparisons.
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Instead the results showed no obvious trends between groups, other than the similarities
between controls.
Table 5: Pixel-based colocalization results for PCP4 experimental groups.
Age

Comparison

mPFC
SSp
Pearson
M1
M2
Pearson
M1
M2
Type I
0.076
0.203
0.068
0.367
0.442
0.352
P1
Type II
0.007
0.114
0.021
0.018
0.134
0.030
Control
0.254
0.458
0.232
0.198
0.408
0.154
Type I
0.187
0.320
0.163
0.186
0.152
0.371
P7
Type II
0.116
0.308
0.106
0.059
0.111
0.078
Control
0.392
0.662
0.331
0.340
0.699
0.218
Abbreviations: Control, CTIP2/SATB2 comparison; Type I, CTIP2/PCP4 comparison;
Type II, SATB2/PCP4 comparison; mPFC, Medial prefrontal cortex; SSp, Primary
somatosensory cortex; Pearson, Pearson’s coefficient; M1, Manders’ coefficient 1; M2,
Manders’ coefficient.
Table 6: Pixel-based colocalization results for TCERG1L experimental groups.
Age

Comparison

mPFC
SSp
Pearson
M1
M2
Pearson
M1
M2
Type I
0.005
0.062
0.037
0.159
0.144
0.340
P1
Type II
0.009
0.171
0.016
0.335
0.452
0.368
Control
0.264
0.587
0.215
0.204
0.462
0.160
Type I
0.075
0.085
0.157
0.075
0.079
0.171
P7
Type II
0.488
0.511
0.451
0.287
0.372
0.254
Control
0.406
0.800
0.257
0.417
0.726
0.300
Abbreviations: Control, CTIP2/SATB2 comparison; Type I, CTIP2/TCERG1L
comparison; Type II, SATB2/TCERG1L comparison; mPFC, Medial prefrontal cortex;
SSp, Primary somatosensory cortex; Pearson, Pearson’s coefficient; M1, Manders’
coefficient 1; M2, Manders’ coefficient.

Object-based methods showed cell type specific differences for PCP4.
Automated cell counts agreed with manual cell counts on 87.5% (28/32 Fisher’s exact
tests) of experiments. A Chi-square goodness of fit test comparing all manual and
automated cell counts also showed no significant difference between groups (Χ2=992, X2
critical=1034, df=961, p=0.237). Power analysis showed that the minimum sample size
of images required to observe the expected effect size was 18, well below the 42 images
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quantified for PCP4 and the 45 quantified for TCERG1L. Even at a lower Cohen’s d of
0.30, the required sample size only increases to 31. This shows that my datasets have
more than enough power to detect the expected effect sizes (1-β for PCP4: 0.995, 1-β for
TCERG1L: 0.997).
The highest colocalization ratio for PCP4 is with the Type I marker (CTIP2),
whereas colocalization with the Type II marker (SATB2) is comparable to that of the
control comparison (Table 7). Other than low overall colocalization, there are no
discernible trends between TCERG1L and either of the Type markers (Table 8).
Table 7: Object-based colocalization ratio of PCP4+ neurons
mPFC
SSp
Type I Type II Control Type I Type II Control
P1
0.072
0.572
0.027
0.096
0.763
0.033
P7
0.463
0.098
0.122
0.327
0.090
0.144
The Type I ratio is the highest in each group. The Type II and
Control ratios are similar. Abbreviations: Type I, CTIP2/PCP4
comparison; Type II, SATB2/PCP4 comparison; Control,
CTIP2/SATB2 comparison.
Table 8: Object-based colocalization ratio of TCERG1L+ neurons
mPFC
SSp
Type I Type II Control Type I Type II Control
P1
0.000
0.010
0.073
0.112
0.049
0.098
P7
0.075
0.168
0.148
0.079
0.065
0.185
No discernible relationships are present between groups. The
control ratios are similar to that of PCP4, but higher in all
groups. Abbreviations: Type I, CTIP2/PCP4 comparison; Type
II, SATB2/PCP4 comparison; Control, CTIP2/SATB2
comparison.
The results of the object-based analyses were conclusive for both putative
markers. The hypotheses were supported with PCP4 but rejected for TCERG1L. The
highest ratio of colocalized cells in each age and tissue group was between CTIP2 and
PCP4, meanwhile SATB2 colocalized with CTIP2 and PCP4 at approximately the same
rate (Figure 11). Multiple linear regression analysis yielded a statistically significant
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model overall (F=43.49, R2=0.806, p=1.68x10-13). However, there were no significant
relationships with age (p=0.192) or brain region (p=0.165). Those non-significant
variables were removed stepwise and marker type remained as the only significant
predictor variable of colocalized proportion (F=81.39, R2=0.797, p=1.21x10-14). The
F-statistic increased from 43.49 to 81.39 after excluding these variables. The R2 only
dropped from 0.806 to 0.797 showing that the influence of age and region, if any, is
negligible in comparison to cell type.

Figure 11: Object-based colocalization: PCP4. Type I, CTIP2/PCP4 comparison; Type
II, SATB2/PCP4 comparison; Control, CTIP2/SATB2 comparison. The whiskers show the
IQR for each group. Type I colocalization is significantly higher in both age and brain
regions.
TCERG1L did not colocalize well with either CTIP2 or SATB2. This held true
with both age groups and tissue types. There are also no obvious trends in the data and
much lower overall rates of colocalization, with groups overlapping to a high extent
(Figure 12). The control groups are similar to that of the PCP4 experiments with median
values falling somewhere around 0.10 to 0.20. Multiple linear regression analysis also
yielded a statistically significant model with TCERG1L (F=4.11, R2=0.220, p=0.00702).
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However, there were no significant differences with brain region (p=0.376) or marker
type (p=0.0962).

Figure 12: Object-based colocalization: TCERG1L. Type I, CTIP2/ TCERG1L
comparison; Type II, SATB2/ TCERG1L comparison; Control, CTIP2/SATB2
comparison. The whiskers show the IQR for each group.
The linear model for age was also significant (F=10.01, R2=0.17, p=0.00286) as
was the resulting t-test (t=-3.22, p=0.00244). It is important to realize that these results,
despite significance, do not support the hypothesis. They are consistent with a slight
increase in overall positive staining with TCERG1L between the age groups, but there are
still no significant differences for colocalization with marker types. In other words, these
results suggest that TCERG1L expression increases with age in these neurons, but does
not differ between brain region (mPFC vs. SSp) or neuron type (Types I vs. II).
Overall, PCP4 is a good candidate marker protein worthy of future study.
TCERG1L does not appear to be so, based on these results. In comparison of pixel-based
and object-based colocalization analysis that object-based methods were much more
useful here. Pixel-based methods are easier to implement but more sensitive to the
different staining patterns of PCP4 and the noisy images of TCERG1L. The development
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of automated methods was the most technically challenging aspect of this part of the
project, but ultimately was well worth the effort as it will allow the lab to replicate the
same analyses on future projects.
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CHAPTER IV
CONCLUSIONS
Neuroinformatics
H1

The differential gene expression between Type I and Type II neurons is
indicative of the physiological and morphological differences between the
two cell types, with expected gene clusters including genes involved with
neural development and differentiation.

Using Cufflinks and AltAnalyze, we were able to identify fourteen putative cell
type markers (seven Type I, seven Type II), and some of these putative markers are
indicative of the functional and morphological differences between Type I and II layer V
pyramidal neurons of the mouse neocortex, supporting my first hypothesis. Many of the
genes that are identified as potential targets were previously unknown in association with
the target cell types or cortical region. For example INHBA is a known marker for
superficial contralateral projection neurons in layer II/III[2], however it is not mentioned
in the literature in association with the layer V target cells. Despite this, the data show
that expression of this gene is elevated in the Type II neurons; which is interesting given
their shared developmental origins and axonal targets with layer II/III neurons[73].
As a basic science approach, an in-silico analysis provides a useful tactic to
identifying potential phenotypic markers. Even with a low success rate, this approach is
more efficient than relying on serendipity for finding new markers. Considering the
stated importance to the discipline of finding new markers for the purpose of defining
gene signatures[16], this may be one of the most fruitful approaches in this vital work.
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The lineage profiling identified closely related tissues for both cell types such as
brain and fetal spinal cord. The highest correlation was seen with neural progenitors and
visual cortex. Interestingly, neither prefrontal cortex nor somatosensory cortex were
highlighted. That may be due to a lack of understanding of the developing mouse brain,
however it may be that it reflects differences in species, as this lineage analysis is
performed by comparison to a human Wikipathways reference network[74]. A mouse
reference is not currently available for this feature in AltAnalyze but is under
development.
Much of this work is focused on the differences between Type I and II neurons,
but Ontology analysis helped to highlight the similarities as well. Overall the cell types
are very similar, which reflects their developmental proximity. Most of the differences in
Z-score are differences of size not sign. The Z-score gives an idea of how similar the
gene expression is to a specific tissue type, so a gene with a low Z-score means that it is
not correlated with that tissue type. In this case, both Type I and II neurons show negative
Z-scores to several adipose tissue types (perivascular, brown, epididymal and
subcutaneous), however Type I neurons have more negative Z-scores. The low
association to adipose tissue is expected because those tissues are different from
pyramidal neurons functionally as well as ontologically. Conversely, both types show
positive Z-scores for Bone marrow hematopoietic progenitors and Trophoblast stem cells,
with Type II neurons showing a larger Z-score in both cases. These associations are
interesting because they are not functionally similar to pyramidal neurons. However, this
result suggests that there may be similar pathways utilized in the development of all of
these tissue types. Again, however, this figure is produced in reference to a human
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Wikipathways network[74]. Until the same analysis can be performed with a more
relevant reference, the implications of this result are preliminary.
Of course, there are differences between Type I and II neurons, as highlighted in
the results section (Table 3), and those differences are important. The most differentially
expressed Gene ontology classification was “Negative regulation of axon regeneration”,
and three of the other top ten ontologies pertain to neural projections of some type. The
defining feature between these cells is the target of their axons; another well documented
morphological difference is the geometry and size of their apical dendrites[1]. The online
DAVID Ontology also yielded results consistent with this, as many of the most highly
correlated Ontology classifications related to axon guidance or developing neurons. This
suggests that the genes in this network would be good candidates to explore in future
studies of this type; especially Pcp4 and the transcription factors Crym, Tcerg1l and
Lhx2.
Using the lineage profiling analysis in tandem with the GO-Elite network analysis
creates a more complete picture. Network analysis reveals the genes at play between
these two cell types. Both established type markers (Ctip2 and Satb2) are present in the
gene networks. Most of the putative type markers are also present in one or more of the
networks. Their presence within the networks supports the other data sources (tissue fate
network and ontology heatmap) on the importance of these genes in the development of
the neurons. For example, most of the putative type markers are also identified as
markers by onboard software in AltAnalyze.
Some of the genes of interest (Tcerg1l, Shisa2 and Ntng2) are absent from the
network diagrams. It may be that they are not in the networks because they don’t interact
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with the other genes. However, it is important to understand that these networks reflect
the literature. If the genes do not have a strong presence in the literature than they may
not be in the networks at all. Tcerg1l is differentially expressed in various auditory, motor
and premotor regions in the primate neocortex[47], and is potentially associated with
ADHD[50]; but has not been investigated regarding the two layer V neuron types. Ntng2
is associated with layer specific dendritic development in excitatory neurons of the
hippocampus and neocortex[13] and is associated with autism[51], but there is also a lack
of papers looking specifically at Type I and II neurons. Having said that, differential
expression of the putative type markers, based on what is known about them, would be
consistent with documented phenotypic differences.
Another important consideration is that many of the putative markers are
transcription factors (Crym, Tcerg1l and Lhx2), and many of the ontologies identified
through GO-elite and DAVID were associated with transcription regulation of some type.
This is important because small changes in transcription regulation can potentially lead to
large phenotypic differences. Since they govern expression of other genes they are the
most likely gene type to be part of the defining signature for each neuron type.
Eph receptors (Ephrin receptors) and Plexins (Semaphorin receptors) are two
other classes of genes that were over represented in the dataset. They are widely
associated with axon guidance[11], so it is no surprise that they are differentially
regulated in Type I and II neurons. Eph receptors are the largest known subfamily of
receptor tyrosine kinases[12] and are membrane bound receptors of Ephrins. Plexins are
membrane bound receptors of Semaphorins and one of the putative Type II markers,
Plxna4, belongs to this class of proteins. Both Ephrins and Semaphorins are repulsive
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signals for the axonal growth cone. Their presence indicates that the developing neurons
are actively expressing different membrane receptors helping guide them to their
different targets and are thus critically involved in axonal pathfinding.
Adding to that, at least four of the fourteen putative type markers are transcription
factors (Crym, Tcerg1l, Ctip2, Lhx2 and possibly Cux2). Crym, Tcerg1l and Ctip2 are
Type I markers, while Lhx2 and Cux2 are Type II markers so it is possible that they are
regulating genes specific to each neuron type. Of these five genes only Ctip2 has been
shown to functionally regulate axonal development so far[16]. The other four are
potentially involved in axonal regulation and all four have been observed in either Type I
or II neurons in other brains regions.
Colocalization Analysis
H2

Tissue sections double stained with markers established in the literature
and the proposed markers, will align with their predicted marker identities
from Hypothesis 1.

Imaging supported Hypothesis 2 for PCP4 as a type marker independent of age or
brain region. The fact that it was relatively stable over age and brain region may make it a
better candidate as a type marker since these neuron types are present throughout the
many regions of the neocortex and at all ages (Figure 8 and Figure 11). This is as
opposed to a marker which might have a more ephemeral expression or is sequestered to
specific regions. It is important to bear in mind that even though it was expressed stably
between P1 and P7, it may not continue through to adulthood. Future work to assess
expression in older individuals is essential to better understand the complete
developmental program.
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Imaging did not support Hypothesis 2 for TCERG1L; significant results with
respect to age without a significant relationship for type does not support the hypothesis.
This only supports the fact that overall expression of TCERG1L increases over the first
week of postnatal development in the mouse neocortex. Differences in staining between
medial prefrontal cortex and primary somatosensory cortex at P1 indicates possible
temporal differences over the course of development. Expression of TCERG1L appears
to begin earlier in primary somatosensory cortex than in medial prefrontal cortex (Figure
9 and Figure 12).
It is possible that TCERG1L is also being expressed in other cell types, for
example interneurons or glial cells, and that an increase in other cell types is effectively
washing out the signal from Type I cells. However, the low overall presence of
TCERG1L+ cells, regardless of whether they colocalize with CTIP2+ or SATB2+ neurons,
suggests that it is more likely that TCERG1L is merely a poor marker in these ages and
regions.
Epitope retrieval for TCERG1L seemed to cause greater background noise and
non-specific binding of antibodies. Colocalization ratio for TCERG1L controls were
similar to PCP4 controls but slightly higher in all four experimental groups. While it is
difficult to make concrete conclusions from these kinds of comparisons; the increase was
consistent over all experimental groups and both image analysis methodologies. This
includes the object-based methods, which are not comparing fluorescence intensity but
spatial relationships of objects in a plane, so they are more robust to noise in the images.
Object-based methods did partially support my hypotheses for PCP4, but not for
TCERG1L. For PCP4, colocalization was higher for Type I neurons. The colocalization
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was highest in medial prefrontal cortex at P1 and lowest in primary somatosensory cortex
at P7, however the age and region variables were not statistically significant. When the
non-significant variables are removed stepwise from the model the R2 value will always
drop some with larger drops indicating larger influences on the model. When the age and
region variables were removed the R2 only dropped slightly showing that the influence of
age and region, if any, is negligible in comparison to cell type. This suggests that PCP4 is
a strong candidate as a new marker type in both regions and age groups. PCP4 has been
observed in Type I cells of the primary somatosensory cortex[3]. However, this is the
first evidence that it is also present in the same neuron types of the medial prefrontal
cortex.
Despite significant results for multiple regression analysis of TCERG1L
expression, these results did not support my hypothesis. Only the age variable showed a
significant relationship and there was no significant relationship between cell types. A
low R2 and F-statistic also show the weak correlation and small effect size that was
observed. TCERG1L is therefore not a good candidate marker for these ages or brain
regions based on these results.
Pixel-based methods failed to produce useful results for PCP4 in this experiment.
The method is valid in some cases where fluorescence intensity and staining pattern are
similar. The benefits of this method are that it is easier to implement and conceptualize
than object-based methods[36]. The main risk is sensitivity to noise and different staining
patterns. JACoP and the Pixel intensities code (Appendix C) offered consistent, but
inconclusive, results. Pearson’s and Manders’ coefficients also showed no correlation.
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For TCERG1L, these results matched the images. TCERG1L does not appear to
colocalize with CTIP2 or SATB2 and the pixel-based methods back that up. However,
background noise may still have affected the results. The results for PCP4 are more likely
due to limitations of the method and the unsuitability of the images because of
differences in staining pattern, rather than supporting a lack of evidence. The different
staining patterns observed here are probably due to functional differences between CTIP2
and SATB2 (both transcription factors) and PCP4, which is a small cytosolic calmodulin
binding protein[3,51].
Object-based colocalization was clearly a superior methodology in this
experiment. It is more robust to noise in the images and different staining patterns. Also,
the results of Χ2 test comparing the Object-based image analysis to that of the manual
cell counts shows agreement of 87.5% of cases (28/32). The main benefits of automated
over manual counting is that it provides more objective measures for the colocalization
that is observed, and vastly reduces the time and effort needed to process the images.
Automation even helped identify recording errors in manual counts. Originally, the
manual and automated cell counts only agreed in 75% (24/32) of images. Upon
reexamining the data, a recording error in four of the data points were discovered. Fixing
these errors increased the agreement between methods by 12.5%.
Just as great of a benefit is the increase in processing time. The automation
process is still very labor intensive. Several weeks of troubleshooting, testing and
streamlining were needed to create a useable automated process. Experience with image
processing, programming and statistical analysis is beneficial, maybe even obligatory, to
adequately execute this type of analysis. However, after the protocol was established a
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total of three hours was all that was needed to process more than double the images that
took three and a half weeks of manual counting. A unique protocol must be created for
each set of experiments because of the differences between IHC protocols and high
inherent variability microscopy images[23,34]; but the protocol may be altered for future
studies fairly easily. So, the return on investment of time and effort is outstanding.
A Note of Caution
One of the major considerations about this project is that many of the putative
marker genes identified may not be expressed in the adult mouse tissue. Many of the
differentially expressed genes in the dataset are related to developmental processes,
especially those identified as potential targets[17,75]. Therefore, the developmental time
course of this study will help fill in part of the gaps between P1 and the adult mouse,
providing a valuable characterization of the gene expression changes that are responsible
for the maturation of layer V neurons in the mouse medial prefrontal and primary
somatosensory cortices. I have also identified elevated or down-regulated gene clusters
that are associated with various developmental processes.
Lineage profiling included apparently different cell types. The pathways merely
reflect those that are annotated in the database from the literature[74]. Our current
knowledge poses no limitation to biology though, so nothing precludes nature from using
these genes for alternative purposes in the body; examples of gene pleiotropy are quite
common. It is presumed here that these pathways are serving some other purpose that is
important to the development of these cell types.
The negative results of six of the eight putative markers is problematic. Every
effort was made to optimize the use of the antibodies to obtain positive staining. Many

63
multiple permutations of antibody concentration, incubation time, incubation
temperature, fixation methodology and epitope retrieval were tried for every antibody.
None of these permutations yielded positive staining for those six antibodies.
There are two possibilities for why so many of the experiments resulted in failure.
First, there was no positive staining because the antibodies were faulty. Second, there was
no positive staining because the binding epitope was not available. The two causes end
with the same result and are therefore indistinguishable from each other. If the first
possibility is the case, then it might be rectified by merely purchasing another antibody
(if available) or using another method, such as in situ hybridization (which would not
observe protein expression).
If the latter reason is the cause then another problem arises, there are many
possible sources for this issue. Our original dataset is based on RNA-seq, which uses
chiefly mRNA, but the immunohistochemistry protocol uses antibodies specific to
expressed proteins. There are many molecular steps between the two, and an interruption
of any of those steps could result in the epitope not being present for the antibody to bind.
While the genes identified in the analyses may be differentially expressed, their
respective proteins may not be. The mRNA may not be translated to protein at all. Even if
translated, a fully mature protein often requires post-translational modification, such as
some form of glycosylation. The protein may be sequestered in a vesicle, transported far
away from the soma, rapidly degraded or present in too small of quantities to be observed
via this methodology. The epitope could even be masked by fixation or destroyed by
epitope retrieval. These are all possible issues with immunohistochemistry, and they all
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produce identical results to a faulty antibody. In light of this it is important to
acknowledge that the negative results with these antibodies are not conclusive.
Future Work
The methodology outlined here lays the framework for many future related
studies utilizing other publicly available datasets. Indeed, the same dataset could be used
to make similar comparisons between the two neuron types and Layer VI pyramidal
neurons. Comparison of superficial (layer II/III) and deep (layer V) contralateral
projection neurons would be possible with the dataset from another similar paper[18].
This methodology requires relatively little resources and could be performed utilizing
common techniques such as immunohistochemistry and open source software on
moderately powerful servers.
The same methodology could be used to perform similar studies in different ages
and brain regions. Perhaps the key to understanding brain regionalization rests in
deciphering differential gene expression between regions. Also, the neurons are not fully
matured for several weeks after this time period, so this project could be expanded upon
to observe changes in gene signatures through to adulthood, which is work that is
currently underway in our lab. This might shed light on previously unobserved ion
channels, for example, which could affect the electrophysiological behavior of the mature
neurons.
Different methods for assessing expression of genes such as in situ hybridization
or developmental studies involving the putative markers will be essential to
understanding their role in the developing neurons. This is difficult because a knockout or
mutation of some of these genes is fatal, for example CTIP2 knockout mice
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spontaneously expire at birth[3] as do SATB2 knockouts[25]. These methods could also
be used on animal models of brain disorders to help highlight affected genes and gene
clusters.
The mouse remains an effective animal model for brain function and
development, but there are well known differences between the mouse and primate
neocortex. Type I and II neurons specifically are larger and more numerous with more
elaborate neuronal projection morphologies[10]. This characteristic is even more
pronounced in the human brain. Since many of the most common gene clusters
recognized in my analysis involved neural projection regulatory genes, the basis of our
superior mental abilities may be in evolutionary differences in some of the very genes
identified in this project. Srgap2 for example, which regulated dendritic spine formation
and is evolutionarily important in the human neocortex[76,77], is expressed 1.4 times
higher in Type II neurons in my dataset. Too small of a difference to be identified as a
putative marker in this protocol, but a statistically significant difference nonetheless
(p=0.00564).
As is often the case in basic biology, the results here open more questions than
they close. There are many possible future directions to expand on this project, especially
when taken in concert with the larger body of research on this subject that is currently
underway by multiple labs doing similar studies, mostly at younger ages and other brain
regions. The main contribution here is expanding this line of research into postnatal ages
and to the medial prefrontal cortex. It is critical for this work to continue as these results
suggest that the genes involved continue to change throughout these age groups, and
there are clearly developmental differences between regions.
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APPENDIX C
COLOCALIZATION PROTOCOL
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Colocalization_Protocol.ijm
// This ImageJ macro will run the Complex Mask Batch macro, preprocessing all images
in the source folder for pixel based colocalization. It then batch processes all output
images of the complex mask through the Pixel Intensities macro. After collecting all of
the pixel intensity data for an image it saves the results table in a .csv file in the same
directory for future statistical analysis. It then calls the JACoP plugin to run
colocalization analysis on each output file from the Complex Mask Batch macro and calls
upon the use to save the output files. Save this file into the Macros or Plugins folder in
ImageJ and it will show up in the corresponding menu of the GUI.
// Runs Complex Mask Batch macro to open each tif image file in the selected input
folder and saves that output to the selected output folder.
run("Complex Mask Batch");
// Prompts user to select an input folder with tif image files for Pixel Intensity macro and
JACoP plugin
input = getDirectory("Select input directory for Pixel Intensity and JACoP");
Dialog.create("Select file type for Pixel Intensity and JACoP");
Dialog.addString("File suffix: ", ".tif", 5);
Dialog.show();
suffix = Dialog.getString();
// Prompts user to select an output folder for .csv file output of Pixel Intensity macro
output = getDirectory("Select output directory for Pixel Intensity and JACoP");
// Opens the folder, assigns each file a position in the file list for processing, then calls
intenseFile function for each file
function intenseFolder(input) {
list = getFileList(input);
for (i = 0; i < list.length; i++) {
if(File.isDirectory(list[i]))
intenseFolder("" + input + list[i]);
if(endsWith(list[i], suffix))
intenseFile(input, output, list[i]);
}
}
// Opens each image individually, runs Pixel Intensity macro on open image, saves each
.csv file to the output directory
function intenseFile(input, output, file) {
print("Intensifying: " + input + file);
open(input + file);
//waitForUser("Spot check", "Is this working?");
name = getTitle;
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dotIndex = indexOf(name, ".");
name = substring(name, 0, dotIndex);
// Separates channels and renames them, a Gaussian blur is applied to red
and green channels at a sigma of half the diameter of smallest object of interest.
run("Stack to Images");
name1 = name + "-0001";
selectWindow(name1);
rename("result1");
run("Gaussian Blur...", "sigma=10");
name2 = name + "-0002";
selectWindow(name2);
rename("result2");
run("Gaussian Blur...", "sigma=10");
name3 = name + "-0003";
selectWindow(name3);
rename("result3");
run("Merge Channels...", "c1=result1 c2=result2 c3=result3 create");
selectWindow("Composite");
run("RGB Color");
run("Pixel Intensities");
saveAs("Results", output + name + ".csv"); // caution: this will overwrite
any files with the same name currently in the output folder
close();
run("Close all windows");
//waitForUser("Spot check", "Is this working?");
}
intenseFolder(input);
waitForUser("Finished", "Processing pixel intensities of all files in the folder is
finished.");
// Opens the folder, assigns each file a position in the file list for processing, then calls
jacopFile function for each file
function jacopFolder(input) {
list = getFileList(input);
for (i = 0; i < list.length; i++) {
if(File.isDirectory(list[i]))
jacopFolder("" + input + list[i]);
if(endsWith(list[i], suffix))
jacopFile(input, output, list[i]);
}
}
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// Opens each image individually, runs JACoP plugin on open image, saves Log to the
output directory and prompts user to save other relevant files to output
function jacopFile(input, output, file) {
print("\\Clear");
// Clears the Log window.
print("JACing oP: " + input + file);
open(input + file);
//waitForUser("Spot check", "Is this working?");
name = getTitle;
dotIndex = indexOf(name, ".");
name = substring(name, 0, dotIndex);
// Create a directory with the images name
dir = name+File.separator;
File.makeDirectory(output + dir);
print("");
print(dir);
// Separates channels of input image, red and green channels are used for
colocalization
run("Stack to Images");
name1 = name + "-0001";
selectWindow(name1);
rename("result1");
name2 = name + "-0002";
selectWindow(name2);
rename("result2");
//waitForUser("Spot check", "Is this working?");
run("JACoP ", "imga=result1 imgb=result2 thra=2 thrb=2 pearson overlap
mm cytofluo objdist=500-8000-158.57142857142858-396.4285714285715-true-true-true
objcentpart=500-8000-true-true-true");
selectWindow("Log");
saveAs("text", output + dir + name + ".txt");
// caution: this will
overwrite any files with the same name currently in the output folder
//waitForUser("Spot check", "Is this working?");
waitForUser("JACoP", "Save output files"); // Waits for user input before
finishing colocalization analysis on this image
run("Close all windows");
//waitForUser("Spot check", "Is this working?");
}
jacopFolder(input);
waitForUser("Finished", "Colocalization analysis of all files in the folder is finished.");
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// Batch processing retrieved and modified from
http://imagej.net/Scripting_toolbox#Opening.2C_processing.2C_and_saving_a_sequence
_of_files_in_a_folder
// Save output to .csv file retrieved and modified from code found at:
http://imagej.1557.x6.nabble.com/save-results-table-as-csv-with-custom-nametd5003427.html
// Cobbled together by Ryan Pevey 26/8/2016, feel free to contact with further questions
bioryguy@gmail.com
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APPENDIX D
CREATE 3-CHANNEL IMAGES
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86

APPENDIX E
COMPLEX MASK
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Complex_Mask.ijm
// This ImageJ macro will take an open three channel image stack, split it into its
constituent channels, subtract the background through a complex mask before stitching
the channel back together as an RGB rendered image. The first channel will be red, then
blue, then green. The complex mask is really a simple threshold, determined by the user,
and subtracted from the original channel. Save this file into the Macros or Plugins folder
in ImageJ and it will show up in the corresponding menu of the GUI.
//open("C:\\Users\\PhilFry\\Desktop\\4CH\\Test\\CZI\\PCP4_4CHP1_2016_05_31__11_
37_57(1)TypeI.tif");
// Obtain the name of the open file, then convert the stack to three separate images for
individual processing
name = getTitle;
dotIndex = indexOf(name, ".");
name = substring(name, 0, dotIndex);
run("Stack to Images");
// Select Red channel and ask user for threshold input, then create a mask and subtract it
from original to subtract background
name1 = name + "-0001";
selectWindow(name1);
run("Despeckle");
run("Duplicate...", " ");
selectWindow(name1 + "-1");
run("Threshold..."); // This line can be modified to use any of the built-in threshold
algorithms for faster, more automated image processing
setOption("BlackBackground", false);
waitForUser("Threshold", "Select threshold settings");
// Waits for user input before
finishing image processing on this channel
run("Convert to Mask");
run("Close");
run("Despeckle");
run("Dilate");
run("Invert");
imageCalculator("Subtract create", name1, name1 + "-1");
name1_1 = "Result of " + name1;
selectWindow(name1_1);
rename("result1");
run("Enhance Contrast...", "saturated=0.4");
// Select Green channel and ask user for threshold input, then create a mask and subtract
it from original to subtract background
name2 = name + "-0002";
selectWindow(name2);
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run("Despeckle");
run("Duplicate...", " ");
selectWindow(name2 + "-1");
run("Threshold...");
setOption("BlackBackground", false);
waitForUser("Threshold", "Select threshold settings");
run("Convert to Mask");
run("Close");
run("Despeckle");
run("Dilate");
run("Invert");
imageCalculator("Subtract create", name2, name2 + "-1");
name2_1 = "Result of " + name2;
selectWindow(name2_1);
rename("result2");
run("Enhance Contrast...", "saturated=0.4");
// Select Blue channel and ask user for threshold input, then create a mask and subtract it
from original to subtract background
name3 = name + "-0003";
selectWindow(name3);
run("Despeckle");
run("Duplicate...", " ");
selectWindow(name3 + "-1");
run("Threshold...");
setOption("BlackBackground", false);
waitForUser("Threshold", "Select threshold settings");
run("Convert to Mask");
run("Close");
run("Despeckle");
run("Dilate");
run("Invert");
imageCalculator("Subtract create", name3, name3 + "-1");
name3_1 = "Result of " + name3;
selectWindow(name3_1);
rename("result3");
run("Enhance Contrast...", "saturated=0.4");
// Combine images to create RGB render
run("Merge Channels...", "c1=result1 c2=result2 c3=result3 create");
selectWindow("Composite");
run("RGB Color");
// Close all windows
//run("Close all windows");
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// Complex mask procedure modified from http://imagej.net/Image_Intensity_Processing
// Cobbled together by Ryan Pevey 26/8/2016, feel free to contact with further questions
bioryguy@gmail.com
Complex_Mask_Batch.ijm

// This ImageJ macro batch processes all of the files of an input folder for future image
analysis. It calls on the user to select an input directory with .tif files to process, and an
output directory for the processed files to go into after completion. It will then open each
tif file in the input directory and run the Complex Mask macro on every one in turn
before signifying completion of the processing to the user. Save this file into the Macros
or Plugins folder in ImageJ and it will show up in the corresponding menu of the GUI.
// Select input and output directories
input = getDirectory("Select input directory for Complex Mask");
output = getDirectory("Select output directory for Complex Mask");
// output
directory should be different from parent directory or original files will be overwritten
// Establish file type for batch processing
Dialog.create("Select file type for Complex Mask");
Dialog.addString("File suffix: ", ".tif", 5);
Dialog.show();
suffix = Dialog.getString();
// Opens the folder, assigns each file a position in the file list for processing, then calls
processFile function for each file
function processFolder(input) {
list = getFileList(input);
for (i = 0; i < list.length; i++) {
if(File.isDirectory(list[i]))
processFolder("" + input + list[i]);
if(endsWith(list[i], suffix))
processFile(input, output, list[i]);
}
}
// Opens each image individually, runs Complex Mask macro on open image, saves each
processed image to the output directory
function processFile(input, output, file) {
print("Processing: " + input + file);
open(input + file);
//waitForUser("Spot check", "Is this working?");
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run("Complex Mask");
selectWindow("Composite");
//waitForUser("Spot check", "Is this working?");
rename(input + file);
print("Saving to: " + output);
saveAs("TIFF", output+file);
//waitForUser("Spot check", "Is this working?");
close();
run("Close all windows");
}
processFolder(input);
waitForUser("Finished", "Complex masking of all files in the folder is finished.");
// Batch processing retrieved and modified from
http://imagej.net/Scripting_toolbox#Opening.2C_processing.2C_and_saving_a_sequence
_of_files_in_a_folder
// Cobbled together by Ryan Pevey 26/8/2016, feel free to contact with further questions
bioryguy@gmail.com
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APPENDIX F
PIXEL INTENSITIES

92
Pixel_Intensities.ijm
// This ImageJ macro will take any 24 bit RGB image and return the individual pixel
intensity values for each channel. First, it obtains the intensity data for each pixel
individually. Then extracts each channel intensity from the raw hexadecimal pixel data. If
any of the three values is greater than the stated threshold it then stores it in the Results
table with that pixels corresponding (x and y) coordinates, "raw" hexadecimal value and
blue channel value. It can then prompt the user to decide which folder to save the .csv
results file to and automatically name this output file after the parent image. Save this file
into the Macros or Plugins folder in ImageJ and it will show up in the corresponding
menu of the GUI.
//open("C:\\Users\\PhilFry\\Desktop\\4CH\\Test\\CZI\\PCP4_4CHP1_2016_05_31__11_
37_57(1)TypeI.tif");
// Obtain pixel height and width of image.
h=getHeight();
w=getWidth();
t=0; // Threshold value for blue channel, valid values are between 0 and 255. If blue
channel is thresholded as binary this value should be 0.
//i=50;
//j=50;
if (nResults>=0) run("Clear Results");
// Check whether the results table is empty,
if not clear it.
// Obtain RGB pixel intensity value for each pixel individually.
for (i=0; i<w; i++){
for (j=0; j<h; j++){
c = getPixel(i, j);
//c=getPixel(730,20)
// Pixel data (c) is stored in hexadecimal format so the channels are extracted
below.
b = c&0xff; // extract blue byte (bits 7-0)
r = (c>>16)&0xff; // extract red byte (bits 23-17)
g = (c>>8)&0xff; // extract green byte (bits 15-8)
if (r>t||g>t) { // only extract pixel data if at least one channel intensity is greater
than threshold
k = nResults;
//r = (c>>16)&0xff;
// extract red byte (bits 23-17)
//g = (c>>8)&0xff; // extract green byte (bits 15-8)
// add pixel data to Result table
setResult("x", k, i);
setResult("y", k, j);
setResult("Raw", k, c);
setResult("Red", k, r);
setResult("Green", k, g);
setResult("Blue", k, b);
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// print(nResults,c,r,g,b);
}
}
}
updateResults();
print(nResults);
// Save output to .csv file
/*dir = getDirectory("Select a directory");
name = getTitle;
dotIndex = indexOf(name, ".");
name = substring(name, 0, dotIndex);
saveAs("Results", dir + name + ".csv");
// caution: this will overwrite any files with
the same name currently in the output folder
// For more info on hexadecimal extraction of pixel intensities see:
http://crazybiocomputing.blogspot.com/2011/11/exploring-colors-and-grays-withimagej.html or http://imagej.1557.x6.nabble.com/setPixel-and-getPixel-for-RBG-imagestd5007241.html
// Save output to .csv file retrieved and modified from code found at:
http://imagej.1557.x6.nabble.com/save-results-table-as-csv-with-custom-nametd5003427.html
// Adding data to Results table: http://imagestack.de/IIP%20with%20ImageJ/CHAPTER01/CHAPTER01-3/chapter01-3.html
// Cobbled together by Ryan Pevey 23/8/2016, feel free to contact with further questions
bioryguy@gmail.com
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Appendix G
MANUAL VS AUTOMATIC CELL COUNTS
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manVauto.R
dat <- read.csv("C:/Users/PhilFry/Desktop/4CH/manVauto.csv")
# The doIt function takes the row of dat as an argument and constructs a 2by2 table using
the appropriate columns depending on dat$type. It then performs a Fisher's exact test to
determine statistical significance.
doIt <- function(r) {
if (dat[r,2]=="1mPFC1" || dat[r,2]=="1SMS1" || dat[r,2]=="7mPFC1" ||
dat[r,2]=="7SMS1") {
fish <- as.data.frame(cbind(dat[r,3],dat[r,4]))
fish[2,] <- cbind(dat[r,5],dat[r,6])
}
else {
if (dat[r,2]=="1mPFC2" || dat[r,2]=="1SMS2" || dat[r,2]=="7mPFC2" ||
dat[r,2]=="7SMS2") {
fish <- as.data.frame(cbind(dat[r,3],dat[r,4]))
fish[2,] <- cbind(dat[r,7],dat[r,8])
}
else {
fish <- as.data.frame(cbind(dat[r,3],dat[r,4]))
fish[2,] <- cbind(dat[r,7],dat[r,9])
}
}
print(fish)
fisher.test(fish)
}
doIt(1)
# for test purposes of the doIt function, the tst function performs the same operation as
above with four integers as arguments specified by the user.
tst <- function(a,b,c,d) {
fish <- as.data.frame(cbind(a,b))
fish[2,] <- cbind(c,d)
print(fish)
fisher.test(fish)
}
tst(9,216,3,124)

### Read the dataset into R. Out.csv was automatically extracted from colocalization
protocol log files, marker and type columns added manually for processing.
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summary(dat)
summary(dat$type)

# Create an empty data frame
chi <- data.frame(manCo=numeric(), manNon=numeric(), autCo=numeric(),
autNon=numeric())

# Subset the dat dataset and fill in colocalized and non-colocalized depending on type
for (i in 1:nrow(dat)) {
if (dat[i,2]=="1mPFC1" || dat[i,2]=="1SMS1" || dat[i,2]=="7mPFC1" ||
dat[i,2]=="7SMS1") {
chi[i,] <- as.data.frame(cbind(dat[i,3],dat[i,4],dat[i,5],dat[i,6]), stringsAsFactors =
FALSE) #centANum, centADen
}
else {
if (dat[i,2]=="1mPFC2" || dat[i,2]=="1SMS2" || dat[i,2]=="7mPFC2" ||
dat[i,2]=="7SMS2") {
chi[i,] <- as.data.frame(cbind(dat[i,3],dat[i,4],dat[i,7],dat[i,8]), stringsAsFactors =
FALSE) #centBNum, centBDen
}
else {
chi[i,] <- as.data.frame(cbind(dat[i,3],dat[i,4],dat[i,7],dat[i,9]), stringsAsFactors =
FALSE) #centBNum, totNon
}
}
}
summary(chi)
chi
### Chi-square goodness of fit
chisq.test(chi$manCo/chi$manNon,chi$autCo/chi$autNon)
# Cobbled together by Ryan Pevey 3/9/2016, feel free to contact with further questions
bioryguy@gmail.com
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APPENDIX H
FIGURE CREATION AND STATISTICAL ANALYSIS
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ex.R
# This script processes the ex master dataset; it is partnered with the autCount.R script.
All figure creation and final processing is performed in this script.
# Define PCP4 subsets
pcp <- subset(ex, ex$marker == "PCP4")
pcp1 <- subset(pcp, pcp$age == "p1")
pcp7 <- subset(pcp, pcp$age == "p7")
summary(pcp)
pcp1m <- subset(pcp1, pcp1$tissue == "mPFC")
pcp1s <- subset(pcp1, pcp1$tissue == "SMS")
pcp7m <- subset(pcp7, pcp7$tissue == "mPFC")
pcp7s <- subset(pcp7, pcp7$tissue == "SMS")
# Define TCERG1L subsets
tce <- subset(ex, ex$marker == "TCERG1L")
tce1 <- subset(tce, tce$age == "p1")
tce7 <- subset(tce, tce$age == "p7")
summary(tce)
tce1m <- subset(tce1, tce1$tissue == "mPFC")
tce1s <- subset(tce1, tce1$tissue == "SMS")
tce7m <- subset(tce7, tce7$tissue == "mPFC")
tce7s <- subset(tce7, tce7$tissue == "SMS")
# Plots
library(lattice)
library(ggplot2)
# PCP4 plots
plot(pcp$colocal/pcp$noncoloc~pcp$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "All PCP4")
plot(pcp1$colocal/pcp1$noncoloc~pcp1$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "P1 PCP4")
plot(pcp7$colocal/pcp7$noncoloc~pcp7$exp, xlab = "Cell type", ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "P7 PCP4")
plot(pcp1m$colocal/pcp1m$noncoloc~pcp1m$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at
P1 in mPFC")
plot(pcp1s$colocal/pcp1s$noncoloc~pcp1s$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at
P1 in SSp")
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plot(pcp7m$colocal/pcp7m$noncoloc~pcp7m$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at
P7 in mPFC")
plot(pcp7s$colocal/pcp7s$noncoloc~pcp7s$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type I", "Type II", "Control"), main = "PCP4 colocalization at
P7 in SSp")
par(xpd=TRUE)
plot(pcp$colocal/pcp$noncoloc~pcp$type, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control",
"Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control"), main = "Object based
PCP4 colocalization", las = 2)
mtext("P1", side = 3, line = 0, adj = 0.25)
mtext("P7", side = 3, line = 0, adj = 0.75)
mtext("mPFC", side = 1, line = 4, adj = 0.125)
mtext("SSp", side = 1, line = 4, adj = 0.375)
mtext("mPFC", side = 1, line = 4, adj = 0.625)
mtext("SSp", side = 1, line = 4, adj = 0.875)
segments(x0=6.5, y0=0.0, x1=6.5, y1=0.8)
segments(x0=3.5, y0=0.0, x1=3.5, y1=0.8, lty = 2)
segments(x0=9.5, y0=0.0, x1=9.5, y1=0.8, lty = 2)
segments(x0=0.75,y0=-0.39,x1=0.75,y1=-0.42)
segments(x0=3.25,y0=-0.39,x1=3.25,y1=-0.42)
segments(x0=0.75,y0=-0.42,x1=3.25,y1=-0.42)
segments(x0=3.75,y0=-0.39,x1=3.75,y1=-0.42)
segments(x0=6.25,y0=-0.39,x1=6.25,y1=-0.42)
segments(x0=3.75,y0=-0.42,x1=6.25,y1=-0.42)
segments(x0=6.75,y0=-0.39,x1=6.75,y1=-0.42)
segments(x0=9.25,y0=-0.39,x1=9.25,y1=-0.42)
segments(x0=6.75,y0=-0.42,x1=9.25,y1=-0.42)
segments(x0=9.75, y0=-0.39, x1=9.75, y1=-0.42)
segments(x0=12.25, y0=-0.39, x1=12.25, y1=-0.42)
segments(x0=9.75, y0=-0.42, x1=12.25, y1=-0.42)

plot(pcp$thrM1~pcp$type, xlab = NULL, ylab = NULL, names = c("Type 1", "Type 2",
"Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1",
"Type 2", "Control"), main = "Proportion of Ch 1 colocalized with Ch 2", las = 2)

100
plot(pcp$thrM2~pcp$type, xlab = NULL, ylab = NULL, names = c("Type 1", "Type 2",
"Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1",
"Type 2", "Control"), main = "Proportion of Ch 2 colocalized with Ch 1", las = 2)
#plot(pcp1$colocal/pcp1$noncoloc~pcp1$type, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control",
"Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control"), main = "P1 PCP4", las =
2)
bwplot(pcp$colocal/pcp$noncoloc~pcp$exp | factor(pcp$age))
#ggplots
qplot(pcp$exp, pcp$colocal/pcp$noncoloc, geom = "boxplot", xlab = "Cell type", ylab =
"Proportion Colocalized", main = "All PCP4")
qplot(pcp1$exp, pcp1$colocal/pcp1$noncoloc, geom = "boxplot", xlab = "Cell type",
ylab = "Proportion Colocalized")
qplot(pcp7$exp, pcp7$colocal/pcp7$noncoloc, geom = "boxplot", xlab = "Cell type",
ylab = "Proportion Colocalized")
#qplot(pcp$exp, pcp$colocal/pcp$noncoloc) + geom_jitter(height = 0.1, width = 0.1)
myPlot<-qplot(x=pcp$exp,y=pcp$colocal/pcp$noncoloc, geom = "boxplot" ,
fill=pcp$exp)
#myPlot + theme_dark() + theme(legend.position='none')
#myPlot + theme(panel.background=element_rect(fill='black'))
#myPlot + annotate("text", x = 2, y = max(pcp$colocal/pcp$noncoloc), label =
"Relationship between x and y")
ggplot(data = pcp1, aes(x=exp, y=colocal/noncoloc)) + geom_boxplot(aes(fill=tissue))

#qplot(pcp$exp, pcp$colocal/pcp$noncoloc) + geom_jitter(height = 0.1, width = 0.1)

#TCERG1L Plots
plot(tce$colocal/tce$noncoloc~tce$exp, xlab = "Cell type", ylab = "Proportion
Colocalized", las = 2)
plot(tce1$colocal/tce1$noncoloc~tce1$exp, xlab = "Cell type", ylab = "Proportion
Colocalized", las = 2)
plot(tce7$colocal/tce7$noncoloc~tce7$exp, xlab = "Cell type", ylab = "Proportion
Colocalized", las = 2)
plot(tce1m$colocal/tce1m$noncoloc~tce1m$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L
colocalization at P1 in mPFC")
plot(tce7m$colocal/tce7m$noncoloc~tce7m$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L
colocalization at P7 in mPFC")
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plot(tce1s$colocal/tce1s$noncoloc~tce1s$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L
colocalization at P1 in SSp")
plot(tce7s$colocal/tce7s$noncoloc~tce7s$exp, xlab = NULL, ylab = "Proportion
Colocalized", names = c("Type 1", "Type 2", "Control"), main = "TCERG1L
colocalization at P7 in SSp")
par(xpd=TRUE)
plot(tce$colocal/tce$noncoloc~tce$type, xlab = NULL, ylab = "Proportion Colocalized",
names = c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1",
"Type 2", "Control", "Type 1", "Type 2", "Control"), main = "Object based TCERG1L
colocalization", las = 2)
mtext("P1", side = 3, line = 0, adj = 0.25)
mtext("P7", side = 3, line = 0, adj = 0.75)
mtext("mPFC", side = 1, line = 4, adj = 0.125)
mtext("SSp", side = 1, line = 4, adj = 0.375)
mtext("mPFC", side = 1, line = 4, adj = 0.625)
mtext("SSp", side = 1, line = 4, adj = 0.875)
segments(x0=6.5, y0=0.0, x1=6.5, y1=0.3)
segments(x0=3.5, y0=0.0, x1=3.5, y1=0.3, lty = 2)
segments(x0=9.5, y0=0.0, x1=9.5, y1=0.3, lty = 2)
segments(x0=0.75,y0=-0.14,x1=0.75,y1=-0.155)
segments(x0=3.25,y0=-0.14,x1=3.25,y1=-0.155)
segments(x0=0.75,y0=-0.155,x1=3.25,y1=-0.155)
segments(x0=3.75,y0=-0.14,x1=3.75,y1=-0.155)
segments(x0=6.25,y0=-0.14,x1=6.25,y1=-0.155)
segments(x0=3.75,y0=-0.155,x1=6.25,y1=-0.155)
segments(x0=6.75,y0=-0.14,x1=6.75,y1=-0.155)
segments(x0=9.25,y0=-0.14,x1=9.25,y1=-0.155)
segments(x0=6.75,y0=-0.155,x1=9.25,y1=-0.155)
segments(x0=9.75, y0=-0.14, x1=9.75, y1=-0.155)
segments(x0=12.25, y0=-0.14, x1=12.25, y1=-0.155)
segments(x0=9.75, y0=-0.155, x1=12.25, y1=-0.155)
plot(tce$thrM1~tce$type, xlab = NULL, ylab = "Proportion Colocalized", names =
c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2",
"Control", "Type 1", "Type 2", "Control"), main = "Proportion of Ch 1 colocalized with
Ch 2", las = 2)
plot(tce$thrM2~tce$type, xlab = NULL, ylab = "Proportion Colocalized", names =
c("Type 1", "Type 2", "Control", "Type 1", "Type 2", "Control", "Type 1", "Type 2",
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"Control", "Type 1", "Type 2", "Control"), main = "Proportion of Ch 2 colocalized with
Ch 1", las = 2)
#ggplots
qplot(tce$exp, tce$colocal/tce$noncoloc, geom = "boxplot", xlab = "Cell type", ylab =
"Proportion Colocalized")
qplot(tce1$exp, tce1$colocal/tce1$noncoloc, geom = "boxplot", xlab = "Cell type", ylab
= "Proportion Colocalized")
qplot(tce7$exp, tce7$colocal/tce7$noncoloc, geom = "boxplot", xlab = "Cell type", ylab
= "Proportion Colocalized")

#####Statistical analysis
pcpLM <- lm(colocal/noncoloc ~ age + tissue + exp, data = pcp)
summary(pcpLM)
anova(pcpLM)
plot(pcpLM)
confint(pcpLM)
pcp.aov <- aov(colocal/noncoloc ~ age + tissue + exp, data = pcp)
summary(pcp.aov)
TukeyHSD(pcp.aov)
pairs(~colocal/noncoloc+age+tissue+exp, data = pcp)
tceLM <- lm(colocal/noncoloc ~ age + tissue + exp, data = tce)
summary(tceLM)
anova(tceLM)
plot(tceLM)
confint(tceLM)
tce.aov <- aov(colocal/noncoloc ~ age + tissue + exp, data = tce)
summary(tce.aov)
TukeyHSD(tce.aov)
#Power analysis
library(pwr)
###Calculate needed sample size
cohen.ES(test = c("anov"),size = c("large"))
pwr.anova.test(k=4,f=0.40,sig.level=0.05,power=0.8)
pwr.anova.test(k=4,f=0.30,sig.level=0.05,power=0.8)
pwr.anova.test(k=4,n=42,f=0.40,sig.level=0.05)
pwr.anova.test(k=4,n=45,f=0.40,sig.level=0.05)
# Cobbled together by Ryan Pevey 20/9/2016, feel free to contact with further questions
bioryguy@gmail.com

